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APC Antigen presenting cell 
BCR B cell receptor 
bHLH Basic helix-loop-helix 
CBA Cytometric bead assay 
CCL Chemokine ligand 
CCR Chemokine receptor 
CD Cluster of differentiation 
cDC Conventional DC 
CDP Common DC progenitor 
CLP Common lymphoid progenitor (identified as lin- Sca-1- c-kit+ IL-7R+) 
CMP Common myeloid progenitor (identified as lin- CD34+ FcγRlo) 
CpG Cytosine (unmethylated)-phosphate-guanosine 
DC Dendritic cell 
dDC Dermal dendritic cell 
dhet Double heterozygote; E47+/-Id2+/-  
dko Double knockout; E47-/-Id2-/- 
E47
ko
 E47 knockout; E47-/-Id2+/- 
EDTA Ethylenediamine  tetra  acetic  acid 
FACS Fluorescence activated cell sorter (flow cytometry) 
FCS Fetal calf serum 
FITC Fluoresceinisothiocyanat 
Flt3 c-fms-like tyrosine kinase 3 
Flt3L c-fms-like tyrosine kinase 3 ligand 
FSC Forward scatter 
GALT Gut- associated lymphoid tissue 
GFP Green fluorescent protein 
GM-CSF Granulocyte macrophage-colony stimulating factor 
hi high 
HLH Helix-loop-helix 
HSC Haematopoietic stem cell 
Hyper IL-6 IL-6/IL-6R fusion protein 
i.v. Intravenous 
Id Inhibitor of differentiation/ DNA binding 
Id2
-/-
  Id2 deficient; Id2-/- 
Id2
ko
 Id2 knockout; E47+/-Id2-/-  
IFN Interferon 
IGF-1 Insulin-like growth factor 1 
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iNOS Inducible nitric-oxide synthase 
IRF Interferon regulatory factor 
ko Knock out 
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lo low 
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M-CSF Macrophage colony-stimulating factor 
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MHC Major histocompatibility complex 
MHC-II Major histocompatibility complex class II 
min Minutes 
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NF-κB Nuclear factor kappa-B 
PAMP Pathogen-associated molecular pattern 
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pDC Plasmacytoid DC 
PP Peyer’s patch 
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RT-PCR Reverse transcriptase polymerase chain reaction 
SCF Stem cell factor 
SD Standard deviation 
SSC Side scatter 
STAT Signal transducers and activators of transcription 
TCR T cell receptor 
TGFβ Transforming growth factor β 
Th1 T helper cell response type 1 
Th2 T helper cell response type 2 
TLR Toll-like receptor 
TNFα Tumour necrosis factor alpha 
TRAF6 TNF receptor associated factor 6 
UV Ultraviolet light 
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Zusammenfassung 
Dendritische Zellen gehören zu den professionellen antigenpräsentierenden Zellen, die 
Antigene aufnehmen und in das Lymphgewebe wandern, wo sie antigenspezifische 
Immunreaktionen initiieren. Verschiedene Subtypen von Dendritischen Zellen wurden 
bereits charakterisiert, abhängig von ihrer Funktion und Lokalisation. Jeder dieser 
Subtypen scheint eine besondere Rolle, sowohl in Immunität als auch in Toleranz zu 
haben. Hingegen ist es weniger klar, wie sich diese verschiedenen Subtypen von 
Dendritischen Zellen aus ihren hämatopoetischen Vorläufern entwickeln und welche 
molekularen Mechanismen an der Regulation der verschiedenen Entwicklungsstufen 
beteiligt sind. 
 
Die vorliegende Arbeit hatte das Ziel einen bereits beschriebenen Vorläufer für 
Dendritische Zellen, den sogenannten „Flt3+ progenitor“, weiterführend zu 
charakterisieren und sein Entwicklungspotenzial in vivo zu untersuchen. Dabei zeigte sich, 
dass der „Flt3+ progenitor“ nicht nur Dendritische Zellen bildet, sondern sich auch in alle 
anderen Zellen des hämatopoetischen Systems entwickeln kann. 
Des Weiteren bearbeitet diese Studie den Einfluss des HLH Transkriptionsfaktors Id2 auf 
die Entwicklung von verschiedenen Subtypen Dendritischer Zellen, insbesondere 
Langerhans Zellen. Da bereits gezeigt wurde, dass Monozyten Vorläufer der Langerhans 
Zellen sein können, wurden Gr-1hi Monozyten sowie der „Flt3+ progenitor“ auf ihre 
Fähigkeit Langerhans Zellen zu bilden untersucht. Dafür wurde ein Mausmodell 
verwendet, in dem Id2 genetisch inaktiviert war. Hierbei wurde gefunden, dass Id2 unter 
normalen Bedingungen essentiell für die Bildung von Langerhans Zellen ist, während 
deren Bildung aus Gr-1hi Monozyten in Antwort auf eine Entzündung unabhängig von Id2 
verläuft. 
 
Es ist bekannt, dass Id2 die Aktivität von E-Proteinen, wie zum Beispiel E47, verändert, 
indem es ihre Bindung an DNS verhindert. Daher wurde der Einfluss von Id2 und E47 auf 
die Entwicklung von Dendritischen Zellen analysiert und diese Arbeit zeigt, dass der 
molekulare Mechanismus, durch den Id2 die Entwicklung von verschiedenen Subtypen 
Dendritischer Zellen kontrolliert, auf einer Beeinflussung von E-Proteinen basiert. 
Zusammen genommen identifiziert diese Arbeit einige der wesentlichen Schritte in der 
Entwicklung von Dendritischen Zellen aus frühen hämatopoetischen Vorläuferzellen. 
Weiterhin betrachtet sie den Beitrag verschiedener Vorläufer zur Entwicklung von 
Langerhans Zellen, sowohl im Normalzustand, als auch während der Entzündung. 
Abschließend zeigt sie die Bedeutung des Zusammenspiels von Id2 und E-Proteinen, wie 
zum Beispiel E47, in der Entwicklung und Differenzierung von Dendritischen Zellen. 
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Abstract 
Dendritic cells are professional antigen presenting cells that capture antigens and migrate 
to lymphoid tissues where they elicit specific immune responses. Several DC subtypes 
have previously been characterised, depending on their function and location. Each 
subtype appears to have a specialised role in both immunity and tolerance. However, less 
clear are the processes by which these different DC subsets develop from haematopoietic 
precursors, and the molecular mechanisms involved in the regulation of the different 
stages during DC development. 
 
The research described herein had the aim to continuatively characterize a previously 
described DC precursor, the Flt3+ progenitor, downstream of the haematopoietic stem 
cells, and to assess its developmental potential in vivo. Hereby, it was found that the Flt3+ 
progenitor does not only develop into dendritic cells, but can also generate all other cells 
of the haematopoietic compartment. 
 
Furthermore, this study examined the role of the HLH transcriptional regulator Id2 on the 
development of different DC subtypes, especially Langerhans cells. As monocytes had 
been assumed to be LC precursors, Gr-1hi monocytes as well as the Flt3+ progenitor were 
tested for their LC precursor potential. Using an Id2 knockout mouse model, it was found 
that Id2 is essential for the formation of Langerhans cells in steady state. Conversely, their 
development from Gr-1hi monocytes in response to inflammation is independent of Id2. 
 
Id2 is known to modulate the activity of E-proteins, such as E47, by antagonising their 
DNA binding. Therefore, the impact of Id2 and E47 on DC development was studied and 
this work provides new insights into the molecular mechanisms controlling the 
development of distinct DC subsets. It shows that the molecular mechanism by which Id2 
controls the development of different DC subtypes is based on a modulation of E-
proteins. 
 
Taken together, this research identified some of the key steps in the development of DCs 
downstream of the early haematopoietic precursors. It also dissected the contribution of 
different precursors for the Langerhans cell development in both the steady-state and 
during inflammation. Finally it provides evidence for the importance of Id2 and E proteins, 
such as E47 working in concert to regulate DC development and differentiation.
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1 Introduction 
1.1 Basic principles of immunity 
Invading pathogens can swiftly replicate and spread within an organism, frequently 
causing severe damage to the host. Due to the constant exposure to potentially harmful 
pathogens, an intricate combination of cellular and humoral factors is required to prevent 
invasion or confine dissemination of pathogens and finally eliminate an infection - the 
immune system.  It consists of two major parts; the innate immune system, and the 
acquired or adaptive immune system. Pathogens first encounter innate immunity, 
comprising, among other components, natural barriers such as the skin and mucosae. 
Should these be overcome by a pathogen, it faces a group of soluble factors, the 
complement system, which can bind to and lyse infectious agents. In addition, the cells of 
the innate immune system constantly circulate through the entire body in search of 
conserved molecular patterns that signal the presence of pathogens. Once detected, 
these are eliminated through phagocytosis by neutrophil granulocytes and macrophages 
[1]. The majority of infections is dealt with by the innate part of the immune system 
without the need for involving adaptive immunity. However, many pathogens have 
developed successful strategies to evade innate immunity, necessitating a more specific 
form of an immune response.  
Whereas the innate immune system mediates a fast, but unspecific reaction, the adaptive 
immune system gives rise to a delayed, but highly specific form of an immune response. It 
is based on two types of effector cells, the B and T lymphocytes. These lymphocytes carry 
specific antigen-recognition receptors, the B cell receptor (BCR) and the T cell receptor 
(TCR), respectively. Upon recognition of an antigen by its receptor, a cell enters a phase of 
rapid proliferation, a process called clonal selection. This leads to a population of cells 
with receptors specific for this particular antigen. After the activation, lymphocytes of the 
adaptive immune system contribute to host defense either by producing antibodies (B 
cells), facilitating the functions of other immune cells such as B cells or macrophages (T 
helper cells), or eliminating infected host cells (cytotoxic T cells). A particularly important 
part of adaptive immunity is the existence of a so-called memory cell repertoire. Upon 
subsequent contact with a previously encountered antigen, memory cells will be 
reactivated, leading to a faster, but still highly specific and efficient response of the 
adaptive immune system [2]. 
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To mount an adaptive immune response a naïve T cell needs to be activated by 
recognition of a foreign antigen via its TCR [3, 4]. But as already said, the TCR of a T cell is 
antigen specific, each T cell carries only one kind of TCR, and the number of T cells specific 
for a certain antigen is very limited. Therefore the chance for a T cell to encounter its 
“matching” antigen is rather low, which makes T cell activation a highly unlikely event [5]. 
To overcome this problem, the body spatially confines naïve lymphocytes to a limited set 
of tissues. The main organs to fulfil this function are spleen and lymph nodes, but also 
different types of mucosa-associated lymphoid tissues, such as Peyer’s patches [6, 7]. 
Naïve lymphocytes are continuously circulating between these tissues in vasculature and 
lymph vessels.  
Moreover, these tissues are specialized to recruit phagocytic cells that carry ingested 
antigen and promote their interaction with naïve lymphocytes, thereby significantly 
increasing the likelihood for an interaction between an antigen and its cognate receptor. 
This is necessary because pathogens often invade peripheral tissues, but not the 
lymphoid system to which naïve T cells are confined. Therefore the professional Antigen-
presenting cells (APCs) overcome the separation between the site of antigen capture, and 
the site of its presentation, by monitoring tissues and organs in the periphery for infection 
[2, 4].  
 
APCs represent a heterogeneous family of cells, including macrophages, monocytes, and 
dendritic cells (DCs). They patrol peripheral tissues, capturing both self and foreign 
antigen. APCs process the antigens into short peptides, which are then loaded onto major 
histocompatibility complex (MHC) molecules, where they are presented to antigen-
specific T cells [8, 9]. Two types of antigen presentation can be distinguished, depending 
on the origin of the antigen. Peptides that are endogenously derived, including viral 
peptides, cellular and tumour antigens are presented to cytotoxic CD8+ T cells via MHC 
class I (MHC-I). On the other hand, peptides that are derived from exogenous antigens, 
which are acquired by endocytosis, are presented to CD4+ T helper cells via MHC-II 
molecules [10-12]. However, there is a certain exception, which is called cross-
presentation. During this, immature DCs are able to present exogenous antigens on MHC-
I molecules, allowing a virus-specific activation of cytotoxic T cells, even if a certain virus 
does not infect APCs [13]. MHC-I is expressed by all nucleated cells of the body, but APCs 
are the only cells that express MHC-II molecules [14]. However, antigen presentation by 
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MHC alone is not sufficient for proper activation of naïve T cells. This requires an 
additional signal, mediated by co-stimulatory molecules such as CD40, CD80, and CD86 
(the latter also being known as B7.1 and B7.2, respectively). These co-stimulatory 
molecules are only expressed on APCs, making them the only group of cells capable of 
activating naïve T cells [2, 15, 16].  
 
1.2 Dendritic cells 
Among APCs, there is one group which is of special importance and most efficient in 
activating T cells, these are the DCs. DCs were first discovered in 1868; by the observation 
of Langerhans cells (LCs) of human epidermis; although they were originally thought to be 
nerve cells [17]. However, it took another century to demonstrate that these cells are in 
fact APCs and belong to the immune system. The seminal work of Steinman and Cohn in 
1973 led to the detection of DCs in lymphoid tissue [18-20]. Following their identification 
and purification, it was realized that DCs have an extraordinary capacity as APCs, being 
efficient inducers of both primary and memory immune responses as well as 
immunological tolerance [21]. 
 
Today, it is known that DCs cover virtually all tissues of the body (Figure 1-1). Immature 
DCs mature in response to stimulation different pathogens and migrate to secondary 
lymphoid organs were they present processed antigen [9]. During their migration, DCs 
acquire full maturity, which is accompanied by an upregulation of MHC molecules and co-
stimulatory molecules, as well as a shut-down of antigen uptake. This process permits DCs 
to be the most efficient activators of T cell stimulation [22]. 
 
All DCs have the ability to take up antigens, process them into antigenic peptides, and 
present these to naïve T cells, resulting in their activation. However, DCs are not a 
homogenous cell population, rather, they are a group of different subtypes, each locating 
to particular tissues of the body, where they fulfil distinct functions [18, 23].  
As the body has to cope with a high number of diverse pathogens, DCs need to adapt to 
different routes of infection, like skin, tissue, mucosa, or blood. And they must be able to 
trigger the appropriate immune response tailored to the specific pathogen [21, 23, 24]. 
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Therefore several functionally distinct DC subsets have developed, of which the most 
important will be briefly summarised here according to their various roles.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-1: Mouse DC populations, location, and turn-over in steady-state.  
Dendritic cells are distributed throughout the body. The major DC sub-populations at haematopoietic sites, 
environmental contact sites, filtering sites, and immune priming sites are depicted. Frequencies are given as 
percent (%) of total nucleated haematopoietic cells. Approximate time to about 50% renewal in steady-
state is given in days (d). * Skin draining lymph node. ** Epidermis. (+) Present, but exact numbers are not 
known. (↑) Present in inflammation. Picture adapted from [25]. 
 
 
1.2.1 Migratory dendritic cells 
Migratory DCs, including for example epidermal LCs and interstitial or tissue DCs, are DCs 
that collect antigens in the periphery and subsequently travel to the draining lymph 
nodes, where they present these antigens. LCs are the only DC type of the epidermis and 
account for 3–5% of all nucleated cells. They form a continuous cellular network through 
their extended dendrites and thereby providing the first immunological barrier to the 
external environment [26]. Even though LCs were integrated into the DC family, they 
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remain a special subgroup among DCs that show certain singularities [26, 27]. One of 
these singularities, which serves as a hallmark of LCs, is the presence of tennis racket-
shaped intracellular structures called Birbeck granules, whose function still remains 
poorly understood [26]. Another characteristic feature is the expression of langerin (also 
known as CD207). Initially, langerin was thought to be solely expressed in cells containing 
Birbeck granules. In the meantime, however, it has also been detected in other cell types 
not containing these structures [26, 28]. The LCs of the epidermis are the classical model 
for migratory DCs [29, 30]. They reside as antigen-sampling sentinels in the skin. From 
here, a small fraction of these cells constantly migrates  to the draining lymph nodes [29, 
30]. During inflammation, the number of migrating cells is significantly upregulated, 
ensuring that in case of an infection an increased amount of antigens from the affected 
area is presented in the lymphoid tissues [8, 31-34].  LCs, as well as other migratory DCs 
remain in an immature state in the periphery. Here, they express only intermediate levels 
of MHC-II and no co-stimulatory molecules. Upon migration in the lymphatics, cell 
maturation leads to a shutdown of antigen uptake and a high expression of MHC-II and 
co-stimulatory molecules, whereby DCs reach the maximal capacity to stimulate naive T 
cells once they have reached the lymph nodes [33, 35]. Nevertheless, it still remains to be 
shown if LCs really present their antigens directly to T cells, or if antigens are transferred 
to  lymph node- resident CD8α+ cDCs for antigen presentation [36-38]. 
Tissue or interstitial DCs are the main DC type found in peripheral tissues. They constitute 
several diverse populations which reside in the periphery, including the DCs of the dermis 
or the lamina propria of mucosae [39, 40]. As LCs, these DCs also migrate to draining 
lymph nodes, both in steady state and during inflammatory processes. However, 
interstitial DCs differ from LCs not only in their location, but in their function. One 
example is that interstitial DCs localize close to the B cell follicles in the outer paracortex 
of the lymph node were they are able to induce naive B cells to differentiate into IgM-
secreting B-1 cells. LCs, on the contrary, settle in the inner paracortex were they mix with 
lymph node-resident langerin+ cells [41]. Another example is their assumed role in 
peripheral tolerance. There is evidence that interstitial DCs are able to act on mature T 
cells in the periphery that escaped negative selection in the thymus, deleting auto-
reactive T cell clones; a mechanism also referred to as “recessive tolerance” [42]. 
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1.2.2 Conventional dendritic cells 
Conventional DCs (cDCs) are also called resident DCs, which highlights a major difference 
to the migratory DCs discussed above: cDCs do not migrate into lymphoid organs from 
the lymphatics. Instead, they reside in lymphoid organs like lymph nodes, where they 
take up and present antigens coming either from the lymph or from migratory DCs. It has 
been estimated that approximately half of the DCs in lymph nodes are resident DCs, 
whereas the remainder has migrated there from the periphery [33, 43]. Not only are 
resident DCs present in significant numbers in all lymphoid organs, they even constitute 
the majority of thymic and splenic DCs [43-45]. In spleen these cells can be further 
subdivided, based on their expression of CD8α+ [45, 46].  
 
The subset of CD8α+ cDCs accounts for up to 15% of splenic DCs and is the dominant DC 
subtype in the thymus [7, 47]. CD8α DCs show some unique functions, which separate 
them from other resident cDCs. Although they are a rather minor population in spleen, 
CD8α+ DCs are the major producers of interleukin (IL)-12 upon activation. During infection 
with intracellular pathogens they are the major subset that efficiently cross-presents 
pathogenic antigens on MHC-I complexes, thereby promoting CD8+ T-cell responses to 
the invading pathogens [47]. In steady state, CD8α+ DCs locate primarily to the T cell 
areas of spleen and lymph nodes [48]. Here they are believed to be involved in immune 
regulatory properties and maintaining self-tolerance by inactivation of potentially auto-
reactive T cells [7, 47, 49]. 
 
The CD8α- cDCs constitute the major subset of DCs in the spleen.  In steady state, CD8α- 
DCs are predominantly found in the marginal zones of the white pulp, but in response to 
contact with agents that stimulate pattern recognition receptors they migrate into the  T 
cell zones [23]. According to their expression of CD4, CD8α- DCs can be sub-divided into 
CD4+CD8α– and CD4–CD8α– cDCs. However, due to their high degree of functional 
similarity, they are frequently considered one single subset, irrespective of the presence 
or absence of CD4 [45, 50]. To date, there is still no information on the particular role of 
CD4-CD8α- cDCs during an infection or in the induction of tolerance, and their 
physiological function remains to be identified.  
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1.2.3 Circulating dendritic cells 
The circulating DC was long thought to be a cDC that migrates through the blood and 
subsequently seeds lymphoid organs. However, cDCs with their characteristic expression 
of CD11chiMHC-II+ are not found in blood, which indicates that these DCs are not 
generally circulating [51]. Instead, circulating DCs can rather be seen as DC precursors 
(pre-DCs), including the type-1 Interferon (IFN) producing plasmacytoid pre-DCs (pDCs) 
[52]. Plasmacytoid DCs are thought to develop in the bone marrow. From here, they 
travel through the blood into the lymphoid organs. Comparable to B cells, pDCs seem to 
be developed and already functional cells [53]. Nevertheless, as indicated by their 
classification as pre-DCs, their maturation seems to be less pronounced than that of cDCs 
[51, 54, 55]. Activation of pDCs occurs after contact with various kinds of pathogens, such 
as viruses and bacteria, but also with pathogen-associated molecular patterns (PAMPs), 
including single stranded RNA and CpG-containing DNA, which are ligands for the Toll-like 
receptors (TLR)-7 - or -9, respectively, which are discussed below (section 1.3.3) [56-59]. 
As a consequence, pDCS react with the production of inflammatory chemokines and 
cytokines. Among others, there is a characteristic burst of IFNα release that is crucial for 
activating neighbouring DCs and limiting viral replication [60]. 
 
Another relevant cell type in the circulation are monocytes. In blood, these cells normally 
express only low levels of Gr-1 (Gr-1lo monocytes), whereas reserves of the less mature 
Gr-1hi subset are retained in the bone marrow. It is still unclear if these monocytes are 
constantly present in the circulation, or if they have the potential to extravasate from 
lymphoid organs in the steady-state, as well [61]. It is, however, known that monocytes 
constitute a precursor with the potential to give rise to fully mature DCs. However, this 
only occurs upon infection or inflammation [62, 63]. Therefore, blood monocytes are 
precursors from which inflammatory DCs can develop. Multiple studies have investigated 
the role of monocytes in the generation of inflammatory dendritic cells, yielding the 
conclusion that at least a proportion of the inflammatory DCs are the progeny of 
monocytes. These have been further characterized as a subset of monocytes that not only 
express CD115, which is typical for the entire monocytic lineage, but also Gr-1, CCR2, and 
L-Selectin [61]. In experiments in which these Gr-1+CCR2+L-Selectin+ monocytes were 
transferred into uninfected, non-irradiated mice, no sign of DC progeny of these cells was 
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found in lymphoid organs, indicating that monocytes do not serve as DC precursors in 
steady-state [64-66]. In contrast, injection of Gr-1+CCR2+L-Selectin+ monocytes during 
inflammation gave rise to DC populations in peritoneum and spleen [64, 66]. 
 
1.3 Development and activation of dendritic cells 
1.3.1 Overview of dendritic cell development 
In general, the remaining lifespan of the majority of DCs is rather short. This necessitates 
a constant replenishment from a pool of precursor cells [67, 68]. The precursors of DCs 
and the developmental pathways that lead to the different DC subtypes are therefore not 
only important for the initial establishment of the many different DC populations 
throughout the body, it is also crucial to preserve effective antigen surveillance by DCs. 
Although the knowledge of DC function is continuously growing, the developmental origin 
of DCs remains rather controversial. One reason for this lies in the great variety of DCs, 
their different locations and function, and their different maturation states.  
 
All cells of the immune system are derived from bone marrow-resident precursors, the 
self-renewing haematopoietic stem cells (HSC), which can develop into a progression of 
cells with an increasing degree of specialization into the different lineages. One of the 
initial steps involves the development of precursors for lymphoid and myeloid cells, the 
common lymphoid progenitor (CLP) or the common myeloid progenitor (CMP), 
respectively (Figure 1-2) [69, 70]. 
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Figure 1-2: Scheme of mouse DC development from bone marrow HSCs and lineage-committed 
progenitors.  
Both cDCs and pDCs can be generated from the Flt3 expressing early myeloid or lymphoid progenitors. Flt3 
ligand is essential for the development of steady-state DC populations. Under inflammatory conditions, i.e., 
in the presence of GM-CSF, monocytes can differentiate into cDCs and LCs (black dash-dotted line). LCs are 
suggested to be maintained locally and independent of circulating precursors in the steady-state. However, 
they most probably also develop from Flt3
+
 CLPs and CMPs via the MDP/CDP (grey dotted line). 
Abbreviations: CDP, common DC progenitor; CMP, common myeloid progenitor; CLP, common lymphoid 
progenitor; GMP, granulocyte and macrophage progenitor; HSC, haematopoietic stem cell; MDP, 
macrophage and DC progenitor; MEP, megakaryocyte and erythrocyte progenitor; MPP, multipotent 
progenitors. Picture adapted and modified from [24]. 
 
 
Based upon a number of similarities with macrophages, DCs were thought to derive from 
a myeloid origin. This was supported by the observation that not only granulocytes, but 
also macrophages and DCs could be grown from a myeloid precursor cell treated with 
granulocyte-macrophage colony-stimulating factor (GM-CSF) [71]. Moreover, splenic and 
thymic cDC and pDC populations were replenished by transfer of CMPs into irradiated 
mice [72-74].  
However, the view of DCs developing from a myeloid precursor and continuously 
migrating via the bloodstream into their respective organs where they give rise to 
progeny was too simple. As stated above, cDCs in thymus, spleen and lymph nodes carry 
CD8α and CD4, as well as some other markers that are normally found on lymphoid cells 
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[46]. This indicates that at least a fraction of DCs may be derived from the CLP. Later it 
was found that a lymphoid precursor cell from murine thymus, which should be a 
precursor for T lymphocytes, did not only yield T cells, but in addition developed into 
CD8α+ thymic cDCs and both CD8α+ and CD8α- DCs in the spleen [73, 75, 76]. A conclusion 
of these experiments was that the CMP might give rise to CD8α- cDCs, whereas CD8α+ 
cDCs are derived from the lymphoid lineage. This idea was overthrown by a detailed 
analysis of the ability of isolated CLPs and CMPs to form different DC subtypes [73, 77, 
78]. Hereby, it was found that all known DC subtypes could be generated from either 
precursor in vivo (Figure 1-2) [72, 73, 77, 79]. This demonstrates a high degree of 
flexibility in the development of DCs, which has to be determined downstream of the 
separation of lymphoid and myeloid lineage. Consequently, the expression of the 
receptor c-fms-like tyrosine kinase 3 (Flt3) was detected on approximately one-third of all 
CMPs and two-thirds of CLPs. Only these Flt3+ progenitor cells are capable of developing 
into DCs (Figure 1-2) [80-82].  
 
However, one DC subpopulation, the LCs, does fit into this concept. In contrast to an 
origin on the bone marrow, LC development could involve a local precursor rather than a 
supply of cells from the circulation [83]. For this, two options exist: First, LCs could have 
the potential for self-renewal, even as mature cells. Second, they could develop from a 
local precursor in the skin rather than bone marrow. One region where such a LC 
precursor could reside is the bulge region of the hair follicle. They contain keratinocytes, 
melanocytes and mast-cell progenitors, and experiments indicate that these follicles are 
sufficient to replace LCs lost as a consequence of damage to the epidermis [84]. Notably, 
this seems to be true only for the steady state. Under inflammatory conditions, LCs are 
replaced from a pool of Gr-1+ monocytes in blood. This process requires the macrophage 
colony-stimulating factor receptor (M-CSFR), pointing towards an important role of 
cytokines in DC development, which is discussed in more detail in the next section [63]. 
 
1.3.2 Role of cytokines in dendritic cell development 
Among the many cytokines involved in the regulation of haematopoiesis, four stand out 
as being of particular importance for DC development: M-CSF, GM-CSF, the ligand of the 
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Flt3 receptor (Flt3L), and transforming growth factor β (TGFβ). There influence on DC 
development is shortly summarized in Table 1-1. 
Table 1-1: The influence of cytokines in DC development. 
Cytokine level alteration DC subsets 
 pDCs CD8α+ cDC 
CD8α- 
cDC 
LCs 
Inflammatory 
DCs 
GM-CSF null ↔ ↔ ↔ ND ND 
GM-CSFR null ↔ ↔ ↔ ↓ ND 
GM-CSF transgenic ND ↔ ↔ ND ND 
GM-CSF administration ND ↔ ↑↑(?) ↑ ↑↑(?) 
GM-CSF over-expression ND ↑ ↑↑(?) ND ↑↑(?) 
Flt3L null ↓↓ ↓↓ ↓↓ ↔ ND 
Flt3L administration ↑↑ ↑↑ ↑ ↓ ND 
M-CSFR null ↔ ↔ ↔ ↓↓ ND 
TGFβ null ↔ ↔ ↔ ↓↓ ND 
Abbreviations: ↑, increased; ↓, decreased; ↔, unaffected; ND, not determined. 
Table adapted from [53]. 
 
As indicated above, mice lacking the receptor for M-CSF cannot repopulate LCs in the 
epidermis depleted by inflammation. In fact, the animals are devoid of monocytes and 
LCs [63, 85]. Whereas M-CSF seems to be required for the formation of LCs, and possibly 
also other types of migratory DCs from Gr-1+CCR2+L-Selectin+ monocytes under 
inflammatory conditions, the influence of M-CSF during steady-state is most likely only of 
minor importance, if any.  
 
Application of GM-CSF to myeloid precursor cells leads to their differentiation into 
granulocytes, monocytes and DCs [71], and administration of GM-CSF increases the 
development of both monocytes and haematopoietic progenitors into myeloid DCs, in 
particular the development of myeloid CD8α- cDCs in the spleen [86]. The effect of GM-
CSF has been utilized as an in vitro culture model, allowing to obtain large numbers of DCs 
from isolated murine bone marrow by a relatively simple procedure [87, 88]. As a 
consequence, the so-called bone marrow derived DCs have become a frequently used 
model system for the investigation of DCs in vitro [88].  
In contrast to the strong effects in vitro, neither the GM-CSF receptor nor the cytokine 
itself are necessary for DC development; mice deficient in either protein were normal 
with respect to cDC and pDC development [89, 90]. This may be based on the fact that 
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GM-CSF is predominantly expressed during inflammation, and its in vivo role may be, 
similar to M-CSF, in the development of inflammatory DCs from myeloid precursors, 
rather than maintenance of steady state DC levels [91, 92].  
 
Flt3L is the ligand for Flt3, which has been mentioned in section 1.3.1 as a characteristic 
marker for the fractions of CLPs and CMPs that have the ability to differentiate into DCs. A 
functional relevance for Flt3 in these events is indicated by the fact that Flt3L is required 
for pDC and cDC development in the steady state [56, 86]. Mice that lack Flt3L or have 
compromised Flt3-dependent signalling pathways show a marked reduction of pDC and 
cDC levels. However, Flt3 is not only involved in the development of DCs; e.g., NK cell 
levels are also affected by a lack of Flt3L. Comparable to GM-CSF, administration of Flt3L 
to mice also leads to elevated levels of DCs [93-96]. Thus, Flt3L has also been used as an 
agent to induce the development of DCs from bone marrow cultures in vitro [93, 97-100].  
 
TGFβ does not have an effect on general DC development. Mice deficient for TGFβ have 
normal levels of pDCs and cDCs of myeloid and lymphoid background. However, TGFβ 
seems to be crucial for LC development, since these mice lack LCs in their epidermis 
completely  [101]. As for M-CSF, GM-CSF, and Flt3L, the effects of TGFβ have also been 
investigated using in vitro cultures. There it was found that TGFβ strongly augmented the 
generation of LCs from CD34+ haematopoietic progenitor cells [102]. Another study aimed 
to pinpoint the event where TGFβ is required for LC development. When lethally 
irradiated wild type mice were injected with bone marrow cells from TGFβ-/- mice, the 
transplanted cells were still able to form LCs. This indicates that the absence of LCs in 
TGFβ-/- mice is not caused by an absence of LC precursors in the bone marrow, but most 
likely based on a requirement of LCs for paracrine stimulation with TGFβ [103].  
 
1.3.3 Role of Toll like receptors in dendritic cell activation 
During an infection, optimal host defence by the adaptive immune system depends on 
the presentation of a sufficient amount of antigen in the lymphoid tissues. Hence, an 
activating signal is required to increase the number of migratory DCs carrying antigens 
from the infected tissue to the site of antigen presentation. Whereas cytokines mediate 
the development DCs, another group of substances is important for their activation. 
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These are pathogen associated molecular patterns (PAMPs), molecular structures that are 
only found in pathogens, but not the host organism, and can therefore serve as a reliable 
indicator for the presence of an infection [1, 104]. These are detected by so-called pattern 
recognition receptors, most importantly the family of Toll-like receptors (TLRs). Thirteen 
TLRs are known in mammals, an overview can be found in table 1-2.  
 
Table 1-2: Toll like receptors 
TLR Expression Ligand(s) References 
1 surface triacyl lipopeptides (as TLR1/2 dimer) [105] 
2 surface various components of Gram-positive and -negative bacteria, 
mycoplasms and yeast, such as peptidoglycan, lipopeptides, 
zymosan 
[106-108] 
3 cytoplasm viral double-stranded RNA [109] 
4 surface lipopolysaccharide from Gram-negative bacteria [110-113] 
5 surface bacterial flagellin [114] 
6 surface diacyl lipopeptides (as TLR2/6 dimer) [115] 
7/8 cytoplasm TLR8 in humans and TLR7 in mice sense viral single-stranded 
RNA and similar synthetic molecules such as 
imidazoquinolines. The respective other TLR is inactive in that 
species. 
[58, 116-
120]  
9 cytoplasm unmethylated CpG-containing sequences in bacterial DNA [121-124] 
10 unknown ligand unknown (TLR10 is functional in humans but not in 
mice) 
[125]  
11 unknown profilin-like protein from Toxoplasma gondii, unknown 
component(s) of uropathogenic E. coli (TLR11 is not found in 
humans) 
[126-128]  
12 unknown TLRs 12 and 13 have only been identified as cDNA in mice, no 
ligands are known 
[129] 
13 unknown 
 
Activation of DCs via their TLRs induces maturation, which has three main features:  
a. DCs react to contact with PAMPs with the secretion of various soluble mediators, 
such as inflammatory cytokines, type I IFN, and chemokines.  
b. Activation of DCs is accompanied by increased surface expression of co-
stimulatory molecules such as CD40, CD80, and CD86.  
c. Triggering of TLRs increases MHC-II presentation on the cell surface. 
The last point bears a potential pitfall. DCs constantly sample antigens from their 
environment for MHC-II presentation to T cells, regardless if these antigens are derived 
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from pathogens or the host. In immature DCs, most MHC-II remains in the late 
endosomes. Upon activation, however, DCs must be able to distinguish between 
endosomes containing self and foreign antigens in order to avoid accidental presentation 
of self-antigens and inducing autoimmunity. Here, TLRs on the surface of the endosomes 
seem to monitor their content, selecting the antigens that the DCs present [130]. 
 
TLRs do not only sense the presence of pathogens in general. TLRs are specific for PAMPs 
associated with a particular group of infecting agents. TLRs 3 and 7 detect double- or 
single-stranded RNAs, respectively, which are of viral origin [109, 116]. In contrast, 
several other TLRs, including TLR 2, 4 and 5, sense bacterial PAMPS. TLR4, e.g., is 
activated by lipopolysaccharide, which is a component of Gram negative bacteria [110-
113]. Additional specificity results from heterodimerisation. A case in point is TLR2. In 
addition to homodimerisation, it also associates with TLR1 and TLR6. TLR2 homodimers 
recognise peptidoglycans, whereas TLR1/2 hetero-dimers respond to triacyl lipopeptides, 
such as Pam3CSK4, and TLR2/6 detects diacyl lipopeptides, such as MALP-2 [105-108, 115]. 
It has been shown that some aspects of DC activation, especially cytokine production, 
depend on the type of TLR by which they were activated. This has an impact on T helper 
cell polarization, stimulating the formation of T cells that mediate an immune response 
which is adapted to the type of pathogen [4]. 
 
1.3.4 Role of transcription factors in dendritic cell development and activation 
The developmental and activating signals that DCs receive from cytokines and PAMPs via 
their respective receptors result in the downstream activation of several transcription 
factors. Differential activation of several transcription factors is involved in orchestrating 
the development of DCs into the different subsets. Table 1-3 summarizes the effects 
excerted by deletion of single transcription factors on the expression of DC subsets in 
mice. 
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Table 1-3: Differential requirements for transcription factors in DC development 
Transcription 
factor 
DC subsets 
 CD4
-
CD8α+ CD4+CD8α- CD4-CD8α- pDC LC 
RelB
-/- +++ - +++ ND +++ 
IRF-2
-/- +++ + ND +++ ++ 
IRF-4
-/- +++ - +++ + ND 
IRF-8
-/- - +++ +++ - ++ 
Ikaros DN - - - ND +++ 
Ikaros
-/- + - - ND ND 
PU.1
-/- ++ - - ND ND 
STAT3
-/- - - - ++? ND 
Gfi1
-/- + + + + ++++ 
Id2
-/- -(+) ++++ + ++++ - 
Runx3
-/- ++++  ++ ND - 
A panel of transcription factor knockout mice and their DC phenotypes. The impact of the targeted gene is 
depicted as increased (++++), normal (+++), reduced (++) or low (+) presence or complete absence (-) of the 
respective DC populations. ND = not determined. Table adapted from [24, 53, 131] 
 
Transcription factors from the nuclear factor (NF)-κB/rel and interferon regulatory factors 
(IRF)-families are involved in both development and activation of DCs. NF-κB is a major 
mediator for TLR-signaling, accompanied by other transcription factors such as AP-1, and 
three members of the IRF-family, IRF-3, -5, and -7 [132]. Especially signals involving the 
adaptor protein myeloid differentiation primary response gene (MyD)88-pathway, which 
leads to the expression of inflammatory cytokines, depend on NF-κB. In contrast, 
expression of type I interferons and co-stimulatory molecules are controlled, amongst 
others, by IRF-3 [132]. 
In addition to their role in TLR-signaling, NF-κB/rel family transcription factors are also 
involved in DC development and subset formation [133-135]. NF-κB/rel factors control 
the development and function of DCs in a complex and subunit-specific fashion. Hereby, 
the RelB subunit seems to have the most profound impact [131]. Deletion of RelB has no 
effects on CD4- DCs and LCs, but abrogates the development of splenic CD4+ DCs. A 
predominant role for RelB in the development of CD4+ DCs, but not CD4- DCs, 
corresponds well to the comparatively higher expression levels of this transcription factor 
that were reported in splenic CD4+ cDCs [133, 134, 136, 137]. Additional indirect evidence 
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for a requirement for RelB in these events comes from defects in CD4+ cDC development 
in mice deficient of TNF receptor associated factor (TRAF) 6, which is located upstream in 
the signalling cascade leading to RelB activation [137].  
Whereas IRF-3, -5, and -7 are involved in DC activation by TLRs, three additional members 
of the IRF family participate in the development of DC subsets. Absence of functional IRF2 
has no impact on pDCs and CD8α+ cDCs, but leads to diminished levels of CD4+CD8α- cDCs 
and LCs [138]. A similar defect was also observed in IRF4-deficient, which have a selective 
defect in splenic CD11bhighCD8α–. Moreover, in vitro cultures of bone marrow from these 
mice also showed impaired development of CD4+CD8α– DCs [139]. IRF8, which is also 
known as ICSBP, has a different effect than IRF-2 and -4. Lowered numbers of splenic 
CD8α+ cDCs were found in the spleens of IRF8 knockout mice. Furthermore,  other DC 
population, namely pDCs and LCs, were also diminished [140-143]. Finally, IRF-4 and -8 
double knockout mice showed severe impairment in the development of all pDCs and 
cDCs, indicating that at least one of these transcription factors seems to be involved in 
the development of all DC subsets [144].  
 
A number of additional transcription factors have been identified, which have no role in 
DC activation or TLR-signalling, but are nevertheless involved in DC development. Some of 
them belong to the family of Ets proteins. Their ability to regulate the expression of a 
wide variety of genes in many tissues and cell types is based on interacting with other, 
structurally unrelated transcription factors [145]. One Ets protein is PU.1, and its 
interaction with IRF-4 and -8 already indicates that it should have an influence on DC 
development. High expression levels of Pu.1 are found in haematopoietic cells that are 
known to be DC precursors, such as HSCs, CLPs, and Flt3+ CMPs [146]. Bone marrow cells 
obtained from Pu.1-deficient mice were not able to develop into DCs during in vitro 
culture with GM-CSF and IL-4 [131]. DCs express high levels of PU.1, and PU.1 is required 
for the development of both cDCs and pDCs [147, 148]. Another transcription factor that 
interacts with PU.1 is Spi-B, which also belongs to the Ets family. In contrast to PU.1, it is 
not expressed in cDCs or myeloid cells, but has been detected in pDCs, B cells, and CD34+ 
haematopoietic progenitors [149, 150]. When cultures of the latter were subjected to Spi-
B or PU.1 knockdown by RNA-interference, they lost their ability to develop into pDCs. In 
the case of Spi-B this instead led to differentiation into B cells and myeloid cells, whereas 
PU.1 knockdown reduced the development of all three cell types [149].  
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Ikaros belongs to the Krüppel family of zinc finger transcription factors. Observations in 
mice expressing a dominant-negative form of Ikaros indicated that this transcription 
factor has a general role in haematopoietic development. Not only were these mice 
lacking all splenic DCs, but also all lymphocytes, namely T, B, and NK cells. 
Notwithstanding, Ikaros knockout mice, which should show a comparable phenotype, 
were only deficient in CD8α- cDCs and pDCs and had impaired development of residual 
CD8α+ cDC, indicating that the role of this transcription factor in DC development requires 
further investigation [151-153]. 
Signal transduction by many cytokines involves one of the seven members of the signal 
transducer and activator of transcription (STAT) family. This is also true for two regulators 
of DC development, Flt3 and GM-CSF. STAT3 is involved in signalling downstream from 
Flt3. Treatment of wild type mice with Flt3L led to a strong increase in splenic DC 
numbers, which was completely abrogated in STAT3-/- mice, demonstrating that STAT3 is 
absolutely necessary for Flt3L-dependent DC development [154]. The transcriptional 
repressor Gfi1 is involved in STAT3 signalling during DC development. Gfi1-deficient 
progenitor cells have decreased STAT3 activity. In accordance with the essential function 
of STAT3 in DC development, the absence of Gfi in vivo resulted in a reduction of myeloid 
and lymphoid DC numbers and function in all lymphoid organs, but elevated numbers of 
LCs in the epidermis. In vitro, hematopoietic progenitor cells from Gfi-1-deficient mice 
were not able to differentiate into DCs in the presence of GM-CSF and IL4 [155]. Flt3L-
mediated pDC development is reduced by addition of GM-CSF in favour of elevated 
formation of cDCs both in vivo and in vitro. It has been shown that STAT5 activation by 
GM-CSF is required for shifting the balance from pDC to cDC generation in response to 
this cytokine [24]. 
In section 1.3.2, TGFβ was introduced as a cytokine critical for LC development. In DCs, 
TGFβ induces expression of the transcription factor Inhibitor of differentiation 2 (Id2). 
Notably, Id2 is also upregulated during development of DCs in vitro [156]. Moreover, Id2 
as well as TGFβ-deficient mice both lack LCs. Hence, it has been suggested that TGFβ acts 
on LC development through regulating the expression of Id2 [131]. Experiments in which 
Id2 was overexpressed in an in vitro culture system of haematopoietic stem cells showed 
that Id2 has no impact on cDC development, whereas it inhibits the development of pDCs 
[157]. The helix-loop-helix (HLH) protein Id2 does not regulate gene expression by binding 
to promoter regions, but instead by binding other transcription factors that also belong to 
Introduction 18 
 
 
the HLH family of transcriptional regulators. Overexpression of two of these factors, HEB 
and E2A in haematopoietic progenitor cultures promotes the formation of pDC [149]. This 
observation suggests that Id2 might antagonize pDC development by binding, and 
thereby inactivating, HEB or E2A. Similar to Id2, Runx3 is another transcription factor 
which is markedly expressed in mature DCs, is under the control of TGFβ, and affects DC 
development. It is unclear if this is based on an interaction with Id2, or if both proteins act 
independently from each other. Regardless, knockout of Runx3 or Id2 in mice results in 
similar alterations in DC subsets. On the one hand, development of LCs in response to 
TGFβ is also impaired in Runx3-/- mice, on the other hand the inhibitory effect of TGFβ on 
other DCs is abrogated in the absence of Runx3 [158].  
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1.4 Aim of the study 
One of the current aims of developmental biology is to understand the mechanisms that 
direct multipotent cells to commit to a single fate. The development of mature lymphoid 
and myeloid cells occurs through the progressive restriction of the developmental options 
of HSCs. Before committing to a particular lineage, HSCs differentiate into multipotent 
progenitors that lack the extensive self-renewal capacity. This thesis continuatively 
examines the previously described Flt3+ DC precursor from mouse bone marrow, 
especially its developmental potential in vivo. 
 
Furthermore, the mechanisms that promote the development of lineage restricted cell 
types, such as DCs from early progenitors, are beginning to be understood at the 
molecular level and include the activity of numerous transcriptional regulatory proteins, 
many of which are member of the HLH protein family. HLH protein expression and activity 
can be regulated by multiple signalling pathways that are active during lineage 
determination. However, the relationship between these pathways and HLH activity 
during the commitment process is currently not known. This research aims to determine 
the importance of Id2 for the development of LCs and other skin DCs as well as for DC 
development in lymphoid organs. Additionally, it analyses whether the development of 
other lymphocytes, especially T cells, is also regulated by Id2. Finally, it determines the 
impact of the antagonism of Id2 and E2A for the development of different DC subsets and 
addresses the question whether lowering E protein activity in Id2-/- mice by deletion of 
the E2A gene product E47 results in the restoration of previously absent DC subtypes. 
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2 Material and Methods 
2.1 Material 
2.1.1 Chemicals 
Unless stated otherwise, all chemicals were obtained from Merck, Fluka or Sigma in 
analytical grade quality. 
2.1.2 Size standards 
DNA size marker: Gene Ruler 1kb ladder 
Gene Ruler 100bp ladder plus 
Gene Ruler 50bp ladder 
Protein size marker: Page Ruler Prestained Protein Ladder 
All from Fermentas. 
2.1.3 Media 
Basic culture medium: RPMI1640 containing 2mM L-glutamine, 100U/ml penicillin, 
100μg/ml streptomycin, 50µM β-mercaptoethanol, and 10% FCS (heat inactivated).  
 
Flt3 precursor amplification medium: Basic culture medium complemented with 30U/ml 
muSCF, 5ng/ml hyperIL-6, 25ng/ml Flt3L, 40ng/ml huIGF-1 long range, 25U/ml muGM-
CSF, and 1pM Dexamethasone. 
 
FL amplification medium: Modified Flt3 precursor amplification medium. Basic culture 
medium complemented with 30U/ml muSCF, 5ng/ml hyperIL-6, 25ng/ml Flt3L, 40ng/ml 
huIGF-1 long range. 
 
GM-CSF medium: Basic culture medium complemented with 200U/ml muGM-CSF 
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Tissue culture additives: 
• All media, L-glutamine, and penicillin/streptomycin were purchased from Gibco-BRL 
• β-mercaptoethanol was obtained from Sigma-Aldrich 
• Fetal Calf Serum (FCS) was supplied by PAA and was heat-inactivated for 30min at 
56°C prior to medium preparation 
• Recombinant murine SCF was produced in SF900 insect cells using baculovirus 
generated with the pETH2a HIS-mSCF plasmid (S.M. Kurz, PhD thesis 2000) 
• Recombinant IL-6/IL-6R fusion protein (Fischer, et al., 1997) was kindly provided by S. 
Rose-John, Christian Albrecht University, Kiel 
• Flt-3L was purchased from PeproTech EC  
• recombinant long-range IGF-1  was obtained from Sigma-Aldrich 
• Murine GM-CSF was produced in E. coli transformed with the plasmid pETH2aHIS-
mGM-CSF (S.M. Kurz, PhD thesis, 2000) 
• Dexamethasone was from Sigma-Aldrich 
 
Table 2-1: TLR ligands 
Name Ligand of Description Concentration 
Working 
concentration 
Pam3CSK4 TLR1/2 
Synthetic Lipoprotein, mimics the acylated 
amino terminus of bacterial lipoprotein 
1mg/ml 1µg/ml 
HKLM TLR2 Heat killed Listeria monocytogenes 10
10
 cells/ml 10
8
 cells/ml 
Poly(I:C) TLR3 
Polyinosine-polycytidylic acid, a synthetic 
analog of double stranded RNA 
10mg/ml 10µg/ml 
LPS-EK TLR4 Lipopolysaccharide from E.coli K12 1mg/ml 1µg/ml 
FLA TLR5 
Bacterial flagellin; major component of the 
flagella filament 
1mg/ml 1µg/ml 
FSL-1 TLR6/2 
Synthetic lipoprotein, represents the N-
terminal part of lipoprotein LP44 of 
Mycoplasma salivarium 
1mg/ml 1µg/ml 
ssRNA TLR7 
single stranded RNA, complexed with 
LyoVec, a cationic lipid; substitues viral 
ssRNA 
2.5mg/ml 2.5µg/ml 
Gardiquimod TLR7 Synthetic ligand for TLR7 1mg/ml 1µg/ml 
CpG 1826 TLR9 
CpG ODN are synthetic oligonucleotides 
containing unmethylated CpG motifs that 
are found in a high frequency in bacterial 
DNA 
5mM 5µM 
All TLR ligands were from Invivogen 
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Table 2-2: Kits 
Kit Manufacturer 
Cytometric Bead Assay BD Bioscience 
Mouse IL-6 Flex Set (bead B4) 
Mouse IL-10 Flex Set (bead C4) 
Mouse IL-12p70 Flex Set (bead D7) 
Mouse MCP-1 Flex Set (bead B7) 
Mouse MIG Flex Set (bead D9) 
Mouse TNFα Flex Set (bead C8) 
High Capacity cDNA Reverse Transcription Kit Applied Biosystems 
NucleoSpin RNA II Macherey & Nagel 
NucleoSpin Tissue Macherey & Nagel 
RNeasy Mini Kit Qiagen 
RNeasy Midi Kit Qiagen 
T7 Mega Script Kit Ambion 
 
Table 2-3: Buffer and solutions 
Buffer Reagents 
10x TBE 0.89M Tris/HCl, 0.89M boric acid, 20mM EDTA 
17% sucrose buffer 88ml 0.1M B2 buffer, 12ml ddH2O, 17g sucrose, pH 7.4 
20mM EDTA 20mM EDTA in PBS  
B2 buffer 13mM NaH2PO4 x H2O, 87mM Na2HPO4 x 2H2O, pH 7.4 
Collagenase solution 1mg/ml Collagenase V in RPMI1640 
EDTA/PBS 2mM EDTA in PBS 
Hank’s buffered saline solution (HBSS) Purchased from Gibco-BRL 
HBSS/PBS 50% HBSS in PBS 
Monocyte wash buffer 0.5% BSA, 2mM EDTA in DMEM 
PFA/PBS 2% PFA in PBS 
Phosphate Buffered Saline  (PBS) Purchased from PAA 
Red blood cells (RBC) lysis buffer 150mM NH4Cl, 100mM NaHCO3, 10mM EDTA in ddH2O, pH adjusted to 7.4 
Saponin buffer 3% FCS, 2mM EDTA, 1% saponin, 0.02% Thimerosal in HBSS/PBS  
Staining buffer 3% FCS, 2mM EDTA, 0.02% Thimerosal in HBSS/PBS 
Trypsin/EDTA 10x trypsin/EDTA purchased from Gibo-BRL 
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Table 2-4: Antibodies for flow cytometry 
Name Cluster of differentiation mAB clone Source 
 CD3ε 145-2C11 eBioscience 
Armenian hamster IgG   BD Bioscience 
B220 CD45R RA36B2 eBioscience 
B4 CD19 MB19-1 eBioscience 
BD CompBead Set anti rat and hamster BD Bioscience 
CCR7 ligand-IgG fusion   Ulrich Kunzendorf 
CSF-1 receptor CD115 AFS98 eBioscience 
E-cadherin  114420 R&D systems 
F4/80, Ly-71  CI:A3-1 AbD Serotec 
Gr-1, Ly6C/6G  RB6-8C5 BD Bioscience 
Heat Stable Ag CD24 M1/69 BD Bioscience 
Integrin α6 chain CD49f GoH3 BD Bioscience 
Integrin-αX CD11c N418 eBioscience 
Langerin CD207 929F3 Alexis 
Ly-2 CD8a YTS169.4 eBioscience 
Ly-4 CD4 GK1.5 eBioscience 
Ly-5 CD45 30-F11 BD Bioscience 
Mac-1 CD11b M1/70 Caltag 
MHC-II  M5/114 eBioscience 
PDCA-1 CD317 eBio927 eBioscience 
Prominin CD133 AC133 eBioscience 
Rat IgG2a   eBioscience 
Rat IgG2b   eBioscience 
Siglec H  440c eBioscience 
Ter119  TER-119 BD Bioscience 
TLR1 CD281 TR23 eBioscience 
TLR2 CD282 6C2 eBioscience 
TLR3 CD283 Polyclonal Alexis 
TLR4 CD284 HTA125 eBioscience 
TLR5  Polyclonal Imgenex 
TLR6  Polyclonal Imgenex 
TLR7  Polyclonal Imgenex 
TLR9  Polyclonal Imgenex 
 
Table 2-5: Antibodies for immunohistochemistry 
Alternative Name Cluster of differentiation mAB clone Source 
langerin CD207 929F3 Alexis 
I-A/I-E  2G9 BD Bioscience 
DAPI   Vector Laboratories 
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2.2 Methods 
2.2.1 Mice 
All experimental mice used were between 8-16 weeks of age. All mice were bred and 
maintained under specific pathogen-free conditions at the University Hospital Aachen 
animal breeding facility, according to institutional guidelines. Mice were killed using 
cervical dislocation. 
Table 2-6: Mice used for experiments in this thesis 
Mouse Genotype Background 
BL/6 BL/6 BL/6 
SV129 SV129 129/SvJ 
Id2 Id2 deficient  129/SvJ 
Id2/E47 Id2 and E47 deficient  129/SvJ x FVB/NJ 
eGFP eGFP knock-in  BL/6 
 
Injections - All intravenous (i.v.) injections were performed using 30-gauge needles. For 
i.v. injections, mice were left under a heat lamp for 15min prior to injection to dilate the 
tail vein. The volume injected was between 50 and 200μl. 
 
Irradiation - For mice that required lethal irradiation prior to cell transfer experiments,  
γ-irradiation was performed using 60Co from a Telecobalt source. Mice were given 5.5 Gy 
twice, 4 hours apart, and cell transfer was performed within 2 hours.  
 
Adoptive transfer of bone marrow and Flt3+ progenitor cells - In vitro amplified Flt3+ 
progenitor cells were generated from bone marrow and transplanted into lethally 
irradiated recipient mice. Different concentrations of Flt3+ progenitor cells or crude bone 
marrow were injected intravenously. In case of Flt3+ progenitor cells transfer, mice were 
always reconstituted with 2x104 unfractionated bone marrow cells to ensure mouse 
survival. 
 
UV irradiation - For LC analysis in normal and inflamed skin ears of sex- and age-matched 
Id2-/- and Id2+/+ mice were incubated for 10min in depilation crème (veet) to remove 
hair. One day later, mice were exposed to UV-C light (wavelength = 254 nm) for 30min at 
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a distance of 30cm to induce ear skin inflammation as described [83] or left untreated. 
Mice were sacrificed at indicated timepoints and ears were taken for further analysis. 
 
2.2.2 Flow Cytometry 
 Analytical flow cytometry was carried out using a FACS Calibur or FACS Canto II (Beckton 
Dickinson). Cell sorting was carried out employing a FACS Aria (Beckton Dickinson). 
Analysis of data was performed using FlowJo software (Treestar). 
 
Compensation - Prior to cell analysis anti-rat/ anti-hamster compensation beads (Beckton 
Dickinson) were used to eliminate spillover of fluorescence from one conjugate into the 
detection channels for other conjugates. Compensation was performed using either the 
instrument software or acquired manually. 
 
Cell preparation - Cells from various preparations (see below) to be analysed or sorted by 
flow cytometry were usually incubated in FcR blocking reagent and 3% mouse serum 
before staining of surface markers. Cells were resuspended at 5x105 cells in 100μl of 
staining buffer containing 0.1µg of the respective antibodies (Table 2-4), stained for 
30min at 4°C, and washed with about 1ml of EDTA/PBS. Prior to analysis, propidium 
iodide (Calbiochem) was added to the sample at a final concentration of 0.5μg/ml to label 
dead cells for subsequent dead cell exclusion. 
 
Intracellular staining - For intracellular staining cells were fixed by resuspending them in 
200µl PFA/PBS and incubated for 10min at room temperature. Cells were washed in 
ETA/PBS and permeabilized in 200µl saponin buffer containing FcR blocking reagent and 
3% mouse serum and incubated for 10min at 4°C. Subsequently cells were washed, 
resuspended in 100µl saponin buffer containing the respective antibodies and incubated 
for 30min at 4°C before further analysis. 
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2.2.3 Isolation of primary cells 
Splenocytes/ thymocytes 
Splenocytes and thymocytes were prepared as follows. Spleens and thymii were chopped 
with scissors and then forced through a cell strainer. Splenocytes were subjected to RBC 
lysis for 5min at room temperature and washed twice in EDTA/PBS. Cells were 
resuspended in staining buffer and stained for FACS analysis.  
 
Bone Marrow cells 
Bone marrow cells were extracted from the tibia and femur with EDTA/PBS using a 1ml 
syringe and 23-gauge needle. The single cell suspension was centrifuged and the pellet 
resuspended in about 1ml RBC lysis buffer for 5min. Cells were washed 2-3 times and 
passed through a cell strainer to remove bone fragments and dead cell clumps. The 
pellets were resuspended in staining buffer and stained for FACS analysis.  
 
Blood monocytes 
To isolate blood monocytes, blood was collected by retro-orbital puncture into 
heparinised tubes. The blood was subsequently subjected to RBC lysis for 5min at room 
temperature and washed twice in Monocyte wash buffer to remove platelets. Cells were 
centrifuged at 4°C at 1400g for 4min, resuspended in staining buffer and stained for FACS 
analysis. All steps were performed at room temperature. 
 
In vivo labelling of blood monocytes 
For labelling of Gr-1hi monocytes, 250µl of liposomes containing clodronate were injected 
intravenously into the tail, followed by i.v. injection of 250µl FITC-conjugated latex 
microspheres 0.5µm in diameter (LX-beads; Polysciences) 18h later [62]. Clodronate (a 
gift from Roche) was incorporated into liposomes as described [159]. 
 
Skin dendritic cells 
Ears were cut off at the base and incubated for 5min in veet depilation crème sensitive 
(veet). Ears were washed twice in PBS and separated into dorsal and ventral halves by 
tearing them apart. Each half was floated on trypsin/EDTA (0.5% for ventral, 0.3% for 
dorsal halves) containing ~20U DNase per ml and incubated for 1h at 37°C. The reaction 
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was stopped by adding 1ml FCS to each well, and the epidermis was carefully detached 
from dermis with forceps. Epidermis and dermis were washed twice in PBS and cut into 
small pieces using fine scissors. Further digestion was performed in 1ml collagenase 
solution for 30- 60min at 37°C on a shaker. Single cell suspension was obtained by 
pipetting the sample up and down several times through a 23-gauge syringe and was 
passed through a cell strainer. Cells were resuspended in staining buffer for further 
analysis. 
 
2.2.4 Dendritic cell cultures 
DC generation from Flt3+CD11b+ progenitor cells (two-step cultures) 
Two-step DCs were generated in culture as described (Figure 2-1) [160]. Bone marrow 
cells were extracted from the tibia and femur of mice and adjusted to 2x106 cells/ml in 
amplification medium. Three days after culture, cells were applied to density gradient 
centrifugation using Ficoll-Hypaque. To recover factor dependent progenitor cells, cells 
from the interphase were collected, washed in RPMI containing 10% FCS, and adjusted to 
2x106 cells/ml in amplification medium. Medium was renewed every second day. At day 7 
of culture differentiation of DC from the proliferating progenitor cells was initiated. Cells 
were washed, transferred to a new dish and adjusted to 2x106 cells/ml in GM-CSF 
medium. Medium was renewed every second day for another 8 days until a population of 
differentiated DCs developed. In some experiments further maturation of DCs was 
achieved by adding TNFα for another 24 hours. 
 
Figure 2-1: Generation of Flt3
+ 
progenitor cells and two-step DCs. 
Flt3
+ 
progenitor cells were amplified from mouse bone marrow using the indicated cytokines. After 7 days 
of amplification, two-step DCs were differentiated from Flt3
+
 progenitors by GM-CSF. 
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DC generation from GM-CSF bone marrow cultures 
GM-CSF generated DCs from mouse bone marrow were prepared as previously described 
[161, 162]. Bone marrow cells were isolated by flushing femur and tibia. Cells were 
resuspended in GM-CSF medium and adjusted to 1 x106 cells/ml. The medium was 
renewed by half every 3 days and fresh GM-CSF was added. Cells were cultured for 8 days 
until a population of differentiated DCs developed. 
 
DC generation from Flt3L bone marrow cultures 
Flt3L DCs were generated in culture as described, but slightly modified [160]. Bone 
marrow cells were extracted from the tibia and femur of mice and adjusted to 2x106 
cells/ml in FL-amplification medium. After three days of culture cells were applied to 
density gradient centrifugation using Ficoll-Hypaque to recover factor dependent 
progenitor cells. Cells were washed and adjusted to 2x106 cells/ml amplification medium. 
Medium was renewed every second day. At day 7 of culture differentiation of DCs from 
the proliferating progenitor cells was initiated. Cells were washed, transferred to a new 
dish and adjusted to 1x106 cells/ml in FL medium. Medium was renewed every third day 
for another 10 days until a population of differentiated DCs developed. 
 
2.2.5 Miscellaneous protocols 
Polymerase chain reaction (PCR) 
RNA prepared from tissue culture cells was purified using the NucleoSpin RNA II Kit 
(Macherey & Nagel) according to manufacturer’s instructions. RNA concentration was 
measured by spectrophotometry using a NanoDrop (Thermo Scientific). Up to 2μg RNA 
were reverse transcribed into cDNA using the High Capacity cDNA Reverse Transcription 
Kit following manufacturer’s protocol. Semi-quantitative PCR was performed to 
determine the expression of indicated genes using the Eppendorf Master Cycler 
(Eppendorf, Germany); 50ng cDNA was used per PCR reaction. The standard PCR protocol 
is given in Table 2-7 
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Table 2-7: Standard PCR protocol 
Step Temperature Cycles 
Initial activation 5min at 95°C 1 
Denaturation 45sec at 95°C 
28-35 Annealing 45sec at 55-60°C 
Extension 1min at 72°C 
Final extension 5min at 72°C 1 
 
Primer for PCR analysis are listed in Table2-8. Hprt1 (encoding hypoxanthine guanine 
phosphoribosyl transferase) or β-actin was used as 'housekeeping' gene control. PCR 
products were resolved on 1% agarose gels.  
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Table 2-8: Primer used for RT-PCR 
Gene 
Annealing 
temperature 
Cycle No. Primer Sequence 
Beta actin 60°C 32 
beta actin-for cgt gcg tga cat caa aga gaa 
beta actin-rev cca tac cca aga agg aag gct 
CCR2 55°C 30 
CCR2-for aca tgt gct aag aat tga ac 
CCR2-rev cct atc aat tgt cag gag ta 
CCR4 60°C 35 
CCR4-for att gct tca tag act gtc ct 
CCR4-rev gat ctt gca cag acc tag t 
CCR7 55°C 30 
CCR7-for aga gag aca aga acc aaa ag 
CCR7-rev act tat aga tgc caa aga tg 
CCR9 55°C 35 
CCR9-for cat gtt cct ttt gaa ttt ag 
CCR9-rev agg tat gaa tga tga tgg ta 
CD11c 55°C 35 
CD11c-for acc tgg ata gcc ttt ctt ctg c 
CD11c-rev tca aaa tct gtg gaa ctg atg c 
HPRT 60°C 32 
HPRT-for gct tgc tgg tga aaa gga cct c 
HPRT-rev tca aaa gtc tgg gga cgc ag 
E-cadherin 58°C 30 
E-cadherin-for gct gga ccg aga gag tta 
E-cadherin-rev tcg ttc tcc act ctc aca t 
Id1 60°C 32 
Id1-for cct gct cta cga cat gaa cg 
Id1-rev tcc tca gaa atc cga gaa gc 
Id2 55°C 28 
mId2-2 for gca tcc ccc aga aca aga ag 
mId2-2445 rev cgt gtt ctc ctg gtg aaa tgg 
Id3 60°C 37 
Id3-for gca ctg ttt gct gct tta gg 
Id3-rev aga tcg aag ctc atc cat gc 
Id4 57°C 33 
Id4-for aac aag aaa gtc agc aaa gtg g 
Id4-rev agc ggt cat aaa aga aga aac g 
Langerin 57°C 32 
Langerin-for aag agt gat gcc cag atg ttg aaa gg 
Langerin-rev ttg ggg tgc gtg aaa agt aat aga ag 
M-CSFR 57°C 28 
M-CSFR-for atg agt ccc tct tca ctc cg 
M-CSFR-rev acc ttc agc act gca tct tc 
TLR1 60°C 32 
TLR1-for gtt ggt gaa gaa ctc agg cg 
TLR1-rev tca gct tgg aca atg aga gg 
TLR2 58°C 30 
TLR2-for atg gca gaa gat gtg tcc g 
TLR2-rev gtc acc atg gcc aat gta gg 
TLR3 58°C 30 
TLR3-for tgg att ctt ctg gtg tct tcc 
TLR3-rev agt tct tca ctt cgc aac gc 
TLR4 59°C 30 
TLR4-for ctg gca tca tct tca ttg tcc 
TLR4-rev gct tag cag cca tgt gtt cc 
TLR5 57°C 35 
TLR5-for ctc atc tca ctg cat acc t 
TLR5-rev agc gag cta atg aat ata ga 
TLR6 62°C 28 
TLR6-for ata tct gag ctt cgg atg cc 
TLR6-rev atg gag aac ggt ggt att gg 
TLR7 62°C 28 
TLR7-for cca cca gac ctc ttg att cc 
TLR7-rev tcc aga tgg ttc agc cta cg 
TLR8 62°C 28 
TLR8-for tgg caa cca tca act tgg gc 
TLR8-rev tgg ctc agg tcc agc act tc 
TLR9 58°C 30 
TLR9-for caa cct ctc ggt gct gga cc 
TLR9-rev cat cat ctg cct ctt cag ggg 
TLR11 58°C 30 
TLR11-for tca ttt tcc ctc cct gcg tc 
TLR11-rev gtg tag ccc aag act cca gcc 
TLR12 62°C 32 
TLR12-for caa ctg cct ggt gac cga ag 
TLR12-rev cga aac cct gga gga gga acc 
TLR13 62°C 28 
TLR13-for tca cct gct cgg aaa cct acc 
TLR13-rev gct cgg aac aac ctg aat ccc 
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TLR stimulation of DCs and Flt3+ progenitor cells 
DCs at day 7 of differentiation or Flt3+ progenitor cells were used for experiments. Cells 
were seeded in 12 well plates at a concentration of 2x106 cells/ml. Cells were stimulated 
with respective TLR ligands for 24h. Concentrations of TLR ligands were used as listed in 
Table 2-1. Supernatant was harvested and used for cytometric bead assay to determine 
secreted cytokine concentration.  
 
Cytometric bead assay (CBA) 
Cytokine secretion of DCs and Flt3+ progenitor cells was assessed after stimulation of cells 
for 24h with various TLR ligands. Culture supernatants were harvested and cytokine 
concentration was determined by Cytometric bead assay (BD Bioscience) according to the 
manufacturer's instructions. In brief, for each single bead or multiplex assay a standard 
curve was prepared by pooling all lyophilized standard spheres into one tube, 
reconstituting them with 2ml of Assay Diluent. A standard curve of 1:1 (undiluted), 1:2, 
1:4, 1:8, 1:16, 1:32, 1:64, 1:128, 1:256 dilutions and only Assay Diluent (zero control) was 
prepared. 
The number of samples and standards were calculated prior to sample preparation. 50µl 
of previously mixed Capture Beads were added to each assay tube. Subsequently 50µl of 
standard or sample were added to the respective assay tube, mixed gently and incubated 
for 1 hour at room temperature. Then 50µl of the previously mixed PE Detection Reagent 
was added to each assay tube, mixed gently and incubate for another hour at room 
temperature in the dark. Finally, 1ml of Wash Buffer were added to each assay tube and 
centrifuged at 200 × g for 5min. The supernatant was carefully aspirated from each assay 
tube. 300µl of Wash Buffer were added to each assay tube and samples were analysed on 
a FACS Canto-II. Cytokine concentration was calculated by FCAP (Soft Flow Inc.) software 
and values of untreated cells were subtracted from stimulated samples. 
 
Fluorescence microscopy 
To determine LC density and morphology, epidermal sheets were subjected to 
immunofluorescence microscopy. First, ears were cut off at the base and incubated for 
5min in veet depilation crème sensitive (veet) to remove hair. Ears were washed twice in 
PBS and separated into dorsal and ventral halves by tearing them apart. Each half was 
fixed on tape (crystal clear, Tesa) and floated on 20mM EDTA for 90 min at 37°C to allow 
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separation of the epidermal sheets from dermis. Epidermal sheets were fixed in 100% ice-
cold acetone for 20min, rinsed in PBS and blocked with staining buffer containing 3% 
mouse serum for 10 min at room temperature before staining with MHC class II-FITC, and 
langerin-Alexa546 overnight at 4°C. Sheets were counterstained with DAPI (Vector 
Laboratories) before being mounted in ProLong Gold mounting medium (Molecular 
Probes). Images were acquired using phase contrast or epifluorescence microscopy with 
an Axiovert 200 microscope (Carl Zeiss, Germany) equipped with a Plan Neofluar 40x/oil 
immersion objective and 1x optovar optics. Images were recorded with a cooled, back-
illuminated charge-coupled device camera (Cascade 512B, Roper Scientific Inc., USA) 
driven by IPLab Spectrum software (Scananalytics, USA). Digital processing of the images 
was done using IPLab Spectrum and Adobe Photoshop (Adobe Systems, USA) 
 
Confocal microscopy and live cell imaging 
Confocal imaging of epidermal sheets was carried out on a Zeiss LSM 510Meta confocal 
microscope (Zeiss, Jena, Germany) with a 63x 1.2 NA Zeiss water immersion objective. 
Alexa546-fluorescence was excited using the 543nm emission line of the helium-neon 
laser, a 543nm dichroic mirror and a 560-600nm bandpass filter. FITC-fluorescence was 
detected using the 488nm emission line of the argon laser, a 488nm dichroic mirror and a 
505-530nm bandpass filter. Image processing was done with the Zeiss LSM image 
browser 4.2 software. The images shown represent confocal slices of ~1µm. 
 
Tissue preparation for transmission electron microscopy 
Samples were fixed in 3% glutaraldehyde in 0.1M B2 buffer for 14h, washed with 0.1M B2 
buffer overnight, followed by 1h in 1% OsO4 in 17% sucrose buffer, rinsed with water and 
successively dehydrated with ethanol (30% - 100%) and propylenoxide (100%). Finally 
tissues were processed for embedding in Epon, polymerized 48h at 60°C, cut into 80-
100nm thick slices and contrasted with uranyl acetate and lead citrate. The samples were 
analyzed with a Philips EM 400 T at 60kV and micrographs were taken by an Olympus 
CCD-Camera Morada. 
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Statistics 
All numerical data were analyzed for significance by a two-tailed and unpaired Student's t 
test with GraphPad Prism software (GraphPad Software Inc.). P values below 0.05 were 
considered to be significant. 
 
Microarray preparation  
Total RNA was isolated with the RNeasy Midi Kit including DNase digestion (Qiagen). 8μg 
of total RNA was used to generate cRNA using a modified protocol from the Expression 
Analysis Technical Manual (Affymetrix). RNA was concentrated to >0.5μg/μl by acid-
ethanol precipitation. For the first-strand cDNA synthesis a T7-oligo(dT) primer was firstly 
hybridised to 8μg of total RNA by denaturation for 10min at 70°C, quick-chilled on ice, 
followed by incubation for 2min at 42°C. The reverse transcription reaction was 
performed using 200U SuperScript-RT (Invitrogen) per sample for 1h at 42°C. The second-
strand cDNA synthesis reaction was carried out by incubating the single-stranded cDNA 
with 10U of DNA ligase, 40U of DNA Polymerase I and 2U of RNaseH for 2h at 16°C, and 
additionally for 5min at 16°C with T4 DNA Polymerase in order to enhance the efficiency 
of the second-strand synthesis. cDNA was cleaned-up using the QIAquick Spin PCR 
Purification Kit (Qiagen). Buffer PB was used for binding: this allows removal of fragments 
smaller than 100bp, i.e. T7-oligo(dT) primers. DNA was eluted with elution buffer. Double-
stranded cDNA was then concentrated again by acid-ethanol precipitation. Synthesis of 
biotin-labelled cRNA was conducted using T7 Mega Script Kit (Ambion). The cDNA 
template was incubated with dNTPs in the presence of Bio-11-CTP and Bio-11-UTP (Perkin 
Elmer) with the T7 RNA Polymerase and the reaction was incubated for 6h at 37°C. cRNA 
was purified using RNeasy Mini Kit (Qiagen). cRNA was then fragmented using the 
fragmentation buffer, and 8μg of cRNA per sample was hybridised to Affymetrix mouse 
MOE430A arrays. DNA chips were stained, washed, and scanned according to the 
manufacturer’s protocol. 
 
All microarray preparation as well as bioinfomatic analysis was performed by Drs. Thomas 
Hieronymus and David Ruau. 
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3 Results 
3.1 Characterization of an in vitro amplified Flt3
+
 precursor  
Many studies in the past few years have addressed the lineage relationships of DCs with 
other haematopoietic lineages. Different DC subsets have been identified both in 
lymphoid and non-lymphoid organs, but their relationship and developmental origins 
remain controversial [23, 81, 163, 164]. Although few DCs in lymphoid organs might 
divide over prolonged time in situ [165], data on the separation of parabiotic mice have 
confirmed previous conclusions from non–self-renewing progenitor cell–transfer 
experiments: most spleen and lymph node DCs must be continuously replaced through 
blood or lymph, most probably by cells originating from haematopoietic stem and 
progenitor cells in the bone marrow [70, 72, 77, 166]. 
Haematopoietic differentiation is a regulated, continuous, and multi-linear process in 
which haematopoietic stem cells (HSCs) give rise to cells of different lineages. This multi-
lineage differentiation is attended by progressively limited developmental options [167] 
and a successive decline in self-renewal potential [168]. The HSC compartment is 
comprised of longterm reconstituting HSCs, which are able to generate all haematopoietic 
lineages for life, and short-term HSCs and their multipotent progenitor (MPP) progeny 
[69, 70, 169, 170], which give rise to all haematopoietic lineages, but with diminished self-
renewal capacity [171-173]. Flt3 is one of the known factors to distinguish between 
longterm and short-term HSCs. In the primitive Lin-Sca-1+c-kit+ (LSK) HSC compartment 
approximately 60% of cells express Flt3 and those cells exhibit short-term reconstituting 
activity, whereas LSK HSC that lack Flt3 expression comprise longterm HSC activity. These 
findings associate Flt3 expression in the HSC compartment with loss of sustained self-
renewal capacity [168, 174, 175].   
 
This section continuatively examines the previously described Flt3+ DC precursor from 
mouse bone marrow [160]. This precursor is amplified in vitro from mouse bone marrow 
with a cocktail of specific cytokines and was shown to differentiate into fully functional 
DCs in vitro in the presence of GM-CSF. This two-step culture system yields homogeneous 
populations of Flt3+ precursor cells in high numbers, thereby overcoming the limitations 
in number, purity, and homogeneity for investigation of such precursors in vivo. 
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Furthermore, it allows detailed analysis of the consecutive steps of DC development in 
vitro under well-defined conditions. 
 
3.1.1 Surface marker profile of the Flt3
+
 precursor 
Haematopoietic cells are frequently characterized by their surface antigen expression. 
The initial phenotypic characterization of the Flt3+ precursor as a precursor for DCs 
revealed the expression of the tyrosine kinase Flt3, along with the stem cell antigens 
CD49f (integrin α6), CD133 (prominin) as well as CD24. Cells were reported to be negative 
for lineage markers, such as CD3ε, CD4, CD8α, CD14, B220, and Ter119, but positive for 
the lineage markers CD11b and Gr-1 (Ly6C/G). As already described, Flt3+ precursor cells 
express neither MHC-II nor CD11c; two commonly used cell surface antigens to determine 
mouse DCs (Figure 3-1). Importantly, expression of these cell surface proteins increased 
during DC differentiation [160, 168]. 
 
Figure 3-1: Surface marker expression on Flt3
+
 precursor cells. 
After 7 days of amplification, Flt3
+ 
precursor cells were stained for indicated markers and their expression 
was analyzed by flow cytometry (blue line). Grey areas represent staining with respective isotype controls. 
Data shown are representative of at least n = 10 independent experiments. 
 
3.1.2 TLR repertoire of the Flt3
+
 precursor cells 
One of the main features of DCs is the recognition of invading pathogens and the 
resulting antigen presentation to naïve T cells to initiate an immune response. TLRs are 
responsible for much of that recognition and consequently have vital roles in the defence 
against pathogens [132]. 
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Besides several well-studied examples of TLRs on mature immune cells, there have been 
some hints that TLRs might influence haematopoiesis. In addition, it would be interesting 
to know when maturing cells in bone marrow acquire functional TLRs.  
Nagai et al. recently reported on early haematopoietic progenitor cells that expressed 
functional TLR2 and TLR4-MD-2. When stimulated with TLR ligands in culture, myeloid 
progenitors gave rise to monocytes and/or macrophages in the absence of exogenous 
growth and differentiation factors, and lymphoid progenitors became DCs [176]. 
If it is assumed that early haematopoietic stem cells already express TLRs, it seems to be 
more than likely that also other types of progenitor cells express TLRs, in particular DC 
precursors. Therefore, Flt3+ DC precursors from in vitro cultures were analyzed for their 
expression repertoire of TLRs.  
 
Comparative gene expression analysis for TLR pathway components 
Gene expression in Flt3+ precursors, differentiated DCs, and TNFα treated (100ng/ml) DCs 
was assessed by DNA microarray analysis. Hierarchical cluster analysis of genes encoding 
for TLRs and respective pathway components was performed, and a representative result 
is shown (Figure 3-2). Rows represent different developmental steps in DC differentiation. 
Cluster I contains genes which are effectively induced during DC differentiation and are 
not further upregulated by TNFα. Genes in cluster II are high in response to TNFα. Cluster 
III comprises genes that are high during DC differentiation and low after activation by 
TNFα. Cluster IV contains genes showing highest expression in Flt3+ precursor cells. 
Finally, Cluster V encloses genes that show a high expression in Flt3+ precursor cells and in 
TNFα stimulated DCs. The heatmap in Figure 3-2 is based on data shown in Table 3-1. 
 
Figure 3-2: Hierarchical cluster analysis of TLR pathway components. 
The Flt3
+
 precursor cells along with differentiated DCs dd10 and DCs dd10 treated with TNFα were 
subjected to transcriptional profiling by DNA microarrays to analyse differentially regulated genes involved 
in TLR pathways. The colour of the respective box in one column represents the expression value of the 
gene transcript in one sample compared to the median expression level of the gene’s transcript for all 
samples shown. Green, transcript levels below median; black, transcript levels equal to median; red, 
transcript levels higher than median. dd, day of differentiation. 
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Expression and up-regulation of TLR mRNA in Flt3+ precursors and differentiated DCs  
To validate the DNA microarray experiments and to determine the regulation of TLR gene 
expression during DC differentiation RT-PCR analysis was employed. Flt3+ precursors and 
DCs were cultured according to the two-step protocol and total mRNA was isolated for 
RT-PCR analysis. This revealed that TLRs 1 to 9 and TLRs 12 and 13 are already expressed 
in the Flt3+ precursor cells and get progressively upregulated during DC differentiation. 
However, expression levels of TLRs 1, 3, 7 and especially TLR12 are rather low in the Flt3+ 
precursors (Figure 3-3). TLR11 is not expressed in the Flt3+ precursor, but gets also 
expressed and upregulated during DC differentiation. Although TLR10 is present in 
human, the mouse homologue is so far not identified.  
 
Figure 3-3: Expression and upregulation of TLRs in Flt3
+
 precursors and differentiating DCs. 
mRNA levels of TLRs in Flt3
+
 precursors and during DC differentiation were determined by RT-PCR. 
Expression levels were investigated at indicated time points. HPRT was used as loading control. dd, day of 
differentiation. Data shown are representative of at least n = 3 independent experiments. 
 
Protein expression of TLRs in Flt3+ precursors and differentiated DCs 
To asses protein levels of TLRs in Flt3+ precursors and differentiated DCs, Flt3+ precursors 
and DCs were cultured according to the two-step protocol and protein expression of TLRs 
was determined by flow cytometry (Figure 3-4). 
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Figure 3-4: Protein expression of TLRs in Flt3
+
 precursors and DCs. 
Flt3
+
 precursors (A) and differentiated DCs (B) were cultured according to the two-step protocol, stained for 
the respective TLRs and their expression was analyzed by flow cytometry (blue line). Grey areas represent 
staining with respective isotype controls. Data shown are representative of at least n = 5 independent 
experiments. 
 
As already established by RT-PCR analysis, TLRs 1 to 9, as well as TLRs 12 and 13 mRNAs 
were expressed in Flt3+ precursor cells. Flow cytometry analysis revealed that TLRs 1 to 7 
and TLR 9 were also expressed on protein levels in Flt3+ precursors. In DCs all these TLRs 
were also expressed and were even further upregulated during differentiation compared 
to Flt3+ precursors (Figure 3-4). TLRs 8, 11, 12, and 13 are so far not well studied and 
reagents and antibodies are difficult to obtain. Thus, the examination of these TLRs was 
not continued. 
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3.1.3 Functional analysis of TLRs on Flt3
+
 precursor and differentiated DCs  
To further investigate functionality of the expressed TLRs in Flt3+ precursors and 
differentiated DCs, cells were stimulated with respective ligands to selected TLRs. 
Supernatants of in vitro cultures were harvested 24h after TLR stimulation and cytokine 
secretion of IL-6, IL-10, IL-12p70, MCP-1, MIG, and TNFα was analyzed by Cytometric 
bead assay (CBA) (Figure 3-5). Cytokine concentration was calculated using FCAP software 
and values of untreated cells were subtracted. 
 
IL-6, MCP-1, and TNFα are rather unspecific pro-inflammatory cytokines, secreted by DCs 
after TLR activation via the MyD88-dependent pathway, whereas MIG is only secreted in 
response to autocrine/ paracrine secretion of IFNβ, which is activated by stimulation of 
TLR3, 7 or 9. IL-12p70, also a pro-inflammatory cytokine, drives polarization of naïve CD4+ 
T cells towards Th1. IL-10 on the other hand is involved in the inhibition of Th1 response 
and differentiation of regulatory T cells, and therefore a rather anti-inflammatory 
cytokine [177-180]. 
 
The analysis of cytokine secretion after TLR stimulation shows that DCs respond 
effectively to TLR stimulation by secreting the examined cytokines. Particularly the 
activation of TLRs 2, 4, 7, and 9 led to a strong cytokine response of DCs, whereas 
activation of TLRs 1/2 and 5 results in only marginal activation of DCs. On the contrary, 
Flt3+ precursor cells were not able to respond properly to any of the TLR ligands, and their 
cytokine secretion remained below 20pg/ml in every case. The low secretion of some 
cytokines in the Flt3+ precursor samples is likely due to a small percentage of 
spontaneously differentiated cells within the culture, which is normally between 3 and 
5%. 
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Figure 3-5: Cytokine production by Flt3
+
 precursor cells and DCs upon TLR stimulation. 
Supernatants of Flt3
+
 precursors (black) and differentiated DCs (white) were harvested 24h after TLR 
stimulation and cytokine secretion was analyzed by CBA. Data shown are means of at least n = 3 
independent experiments ± SD. 
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3.1.4 Analysis of the in vivo developmental potential of the Flt3
+
 precursor 
Several studies demonstrated the developmental plasticity inherent to the DC system, 
showing that both common lymphoid and common myeloid progenitors are able to 
differentiate into all types of DCs [77, 181]. Previous studies already revealed that Flt3+ 
precursor cells give rise to both spleen CD8α+ and CD8α- DCs in vivo [160]. Furthermore, 
the work of Nagai et al. indicates that TLR signalling might not only activate immune 
responses in APCs, but also influences lineage decision of early haematopoietic 
progenitors [176].  
Thus, the developmental potential of the Flt3+ precursor was further examined in vivo in 
cell transfer experiments. Flt3+ precursors of GFP+ mice were amplified in vitro for seven 
days and different concentrations were injected intravenously (i.v.) into lethally irradiated 
mice together with a radio protective dose of 2x104 GFP- bone marrow cells to assure 
mouse survival. Transplantation of unfractionated GFP+ bone marrow was used as 
control. Blood samples were analyzed for GFP+ cells 2, 6, and 10 weeks after 
transplantation and GFP+ cells were further analyzed for expression of linage markers for 
B cells (CD19), T cells (CD3ε), myeloid cells (CD11b), and granulocytes (Gr-1) (Figure 3-6). 
In addition, bone marrow, spleen, and thymus were analyzed at the end of the 
experiment for GFP+ cells, which were further analyzed for expression of linage markers 
for B cells (CD19), T cells (CD3ε), myeloid cells (CD11b), granulocytes (Gr-1), DCs (CD11c), 
macrophages (F4/80), and erythrocytes (Ter119) (Figure 3-7). 
 
Results 43 
 
 
 
Figure 3-6: Repopulation efficiency of the Flt3
+
 precursor in blood after adoptive transfer. 
Flt3
+ 
precursors of GFP
+
 mice were amplified in vitro for seven days. 2x10
6
 (A), 1x10
6
 (B), or 2x10
5
 (C) cells 
were injected intravenously into lethally irradiated mice together with a radio protective dose of 2x10
4
 GFP
-
 
bone marrow cells. Blood samples were analyzed at indicated time points for GFP
+
 cells (light green) and 
lineage marker for T cells (black), B cells (dark red), myeloid cells (grey), and granulocytes (blue).  Injection 
of 2x10
6
 cells of unfractionated bone marrow (D) was used as control. One representative experiment out 
of 4 is shown. 
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Figure 3-7: Repopulation efficiency of the Flt3
+
 precursor in different organs after adoptive transfer. 
Flt3
+ 
precursors of GFP
+
 mice were amplified as described. 2x10
6
 (A), 1x10
6
 (B), or 2x10
5
 (C) cells were 
injected intravenously into lethally irradiated mice together with a radio protective dose of GFP
-
 bone 
marrow cells. 10 weeks after transfer bone marrow spleen and thymus were analyzed for GFP
+
 cells (light 
green) and lineage marker for T cells (black), B cells (dark red), myeloid cells (grey), granulocytes (blue), DCs 
(purple), macrophages (green), and erythrocytes (red).  Injection of 2x10
6
 cells of unfractionated bone 
marrow (D) was used as control. One representative experiment out of 4 is shown. 
 
Preliminary transplantation experiments revealed that the Flt3+ precursor does not 
contain any bone marrow reconstitution capacity, as all mice that were injected with Flt3+ 
precursor cells only died within 5 days. Therefore it was essential to inject a radio 
protective dose of bone marrow cells concomitantly. Irrespective of that the 
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transplantation experiments showed GFP+ cells for at least 10 weeks in blood, bone 
marrow, spleen, and thymus. However, percentages of GFP+ cells in thymus were too low 
to be further analyzed. Furthermore, the data demonstrate that the Flt3+ precursor can 
give rise to all cell lineages tested. It preferentially develops into B cells and myeloid cells, 
which are probably mainly monocytes, but it can also generate T cells, granulocytes, DCs, 
macrophages, and erythrocytes; Table 3-2 is summarising these data. 
 
Table 3-2: Summary of the repopulation efficiency of the Flt3
+
 precursor. 
 Blood Bone marrow Spleen 
Myeloid cells (CD11b) √ √ √ 
DCs (CD11c) n.d. n.d. √ 
B cells (CD19) √ √ √ 
T cells (CD3) √ √ √ 
Granulocytes (Gr-1) √ √ √ 
Erythrocytes (Ter119) n.d. √ n.d. 
Macrophages (F4/80) n.d. √ √ 
n.d., not determined 
 
Several studies already reported that GFP expression in GFP transgenic mice is not 
ubiquitously, but highly variegated. Many cells from GFP mice produce intense GFP 
fluorescence, while cells of the same tissue showed minimal or undetectable GFP 
expression [182]. Unfortunately, that made a reliable quantitative analysis of the donor 
cells impossible, especially as GFP expression is decreasing in many of the cells over time 
[182]. Therefore, the conclusion that can be drawn from these experiments is that the 
Flt3+ precursor does not contain any bone marrow repopulation potential, but does give 
rise to cells of both myeloid and lymphoid origin upon transplantation. As a result, the 
Flt3+ precursor is not only a DC precursor, as already reported, but rather a multipotent 
progenitor for all haematopoietic cell types. 
Results 46 
 
 
3.2 Development of two distinct types of Langerhans cells in steady state 
and inflammation 
Due to their specialized location in skin, LCs constitute the first immune barrier for 
invading pathogens, but have also been implicated in tolerance induction [183, 184]. LCs 
express CD11c, MHC-II, DEC-205 (CD205) and the endocytic receptor langerin (CD207) 
[35]. Langerin is involved in specific intracellular or membrane-bound structures, referred 
to as Birbeck granules that represent a hallmark of LCs [28, 183]. The function of these 
organelles has yet to be fully resolved, although it has been proposed that they are 
involved in antigen uptake and/or processing [28, 185]. 
 
While much is known about LC activation and trafficking towards the skin-draining lymph 
nodes, the developmental origin of LCs and the differentiation factors involved remained 
elusive [131]. Recent studies showed that LCs are maintained by local long-lived 
precursors that seed skin during embryonic development and self-renew under steady 
state conditions [83, 186]. During inflammation, LCs emigrate from skin and are replaced 
by circulating Gr-1hi monocytic LC precursors that are recruited from blood [63]. 
Several gene-deficient mouse models provided novel insights into the molecular 
pathways that are important for LC development [131]. Mice deficient for the 
transcription regulator Id2 (inhibitor of differentiation/DNA binding 2) lack LCs and have a 
severe reduction in splenic CD8α+ DCs [156, 187]. Furthermore, it was demonstrated 
before that TGFβ1 induces expression of Id2 [156] and TGFβ1-/- mice also lack LCs [101, 
188].  
 
This section analyses the importance of Id2 for the development of LCs and other skin 
DCs. It examines whether adoptive transfer of Id2+/+ bone marrow or Id2+/+ Flt3+ 
progenitor cells is able to repopulate the missing LCs in epidermis of Id2-/- mice. 
Moreover, this section questions whether Gr-1hi monocytes that were reported to give 
rise to LCs under inflammatory conditions [63] are able to repopulate the epidermis of 
Id2-/- mice after an inflammatory stimulus. 
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3.2.1 Id2 deficiency results in lack of LCs and langerin
+
 dDCs 
Id2-/- mice lack LCs as determined by immunohistochemistry of epidermal sheets with  
MHC-II and langerin (CD207) specific antibodies (Figure 3-8 A) [156].  
 
Figure 3-8: Id2
-/-
 LC phenotype in epidermis. 
(A) Immunofluorescence staining of skin epidermis from Id2
-/-
 and Id2
+/+
 mice for MHC-II (green) and 
langerin expression (red); nuclear staining with DAPI (blue). (B) Flow cytometry of single-cell suspensions of 
epidermis from Id2
-/-
 and Id2
+/+
 mice. For detection of LCs, cells from epidermal sheets were stained for 
CD45, CD11c and langerin; SSC, Side scatter. (C) Frequency of CD45
+
 cells among total epidermal cells. (D) 
Frequency of LCs among CD45
+
 leukocytes. Data shown are representative of at least n = 4 independent 
experiments ± SD. Scale bar 50µm. *** p < 0.001. 
 
To further extend this observation, single cell suspensions of epidermis and dermis from  
Id2-/- and Id2+/+ mice were analyzed for LCs and dDCs by flow cytometry. This revealed 
that LCs, characterized by CD45, CD11c, MHC-II, and langerin expression, were detected 
in epidermis of Id2+/+ mice, whereas these cells were absent in Id2-/- mice (Figure 3-8, B 
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and D). Furthermore, the flow cytometry data showed that Id2-/- mice not only lack LCs, 
but the entire CD45+ cell population in the epidermis (Figure 3-8, B and C). 
Recent studies identified a subpopulation of dDCs that also express langerin [189-191]. 
Thus, Id2-/- and Id2+/+ mice were analyzed for the presence of langerin+ dDCs using a panel 
of surface markers including CD11c, MHC-II, and langerin (Figure 3-9 A). The CD45+ 
population was decreased in Id2-/- dermis (Figure 3-9 B).  Langerin+ dDCs were detected in 
dermis of Id2+/+ mice, whereas these cells were absent in Id2-/- mice. However, the 
population of CD11c+ MHC-II+ langerin- dDCs was comparable in Id2-/- and Id2+/+ mice 
(Figure 3-9, C and D). 
 
Figure 3-9: Id2
-/-
 dermal DC phenotype. 
(A) Langerin
+
 dDCs were identified by staining for CD45, CD11c, and langerin; SSC, Side scatter. (B) 
Frequency of CD45
+
 cells among total dermal cells. (C) Frequency of DCs among CD45
+
 cells. (D) Frequency 
of langerin
+
 dDCs among total dDCs. Data shown are representative of at least n = 4 independent 
experiments ± SD. n.s. not significant; ** p < 0.01;   *** p < 0.001. 
 
3.2.2 Flt3
+
 bone marrow progenitor cells rescue LC deficiency in Id2
-/-
 mice 
Next, it was explored whether the LC deficiency in Id2-/- mice results from impairment of 
the haematopoietic compartment. Therefore, bone marrow cells of congenic Id2+/+ donor 
mice were used for the reconstitution of lethally irradiated Id2-/- mice. Analysis of 
epidermal sheets showed that within one week after transfer, Id2+/+ bone marrow cells 
were able to repopulate MHC-II+ LCs in epidermis of Id2-/- mice to the full extent as 
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observed in WT mice  (Figure 3-10 A). However, it took three weeks until these cells 
became langerin positive (Figure 3-10 B). Injection of Id2+/+ bone marrow cells into non-
irradiated Id2-/- mice also restored LCs, indicating that LC repopulation was not dependent 
on irradiation-associated events. Bone marrow-derived LCs remained in skin for more 
than 3 months. Injection of Id2-/- bone marrow cells, used as a negative control, did not 
repopulate LCs (Figure 3-10 A), demonstrating that LC development from bone marrow 
cells does require Id2.  
Analysis of dermis showed that Id2+/+ bone marrow cells were able to repopulate 
langerin+ dDCs in Id2-/- mice within two to three weeks. However, repopulation did not 
reach the full extent of langerin+ dDCs observed in untreated WT mice (Figure 3-10 A and 
Figure 3-9). 
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Figure 3-10: Repopulation of skin DCs in Id2
-/-
 mice after adoptive transfer of bone marrow. 
(A) Repopulation of LCs in Id2
-/-
 mice in epidermal sheets after transplantation of Id2
+/+
 bone marrow cells. 
Epidermal sheets were stained for MHC-II (green) and DAPI (blue) 1 week after transplantation. 
Transplantation of Id2
-/-
 bone marrow was used as negative control. (B and C) Flow cytometry of single-cell 
suspensions of epidermis (B) and dermis (C) from Id2
-/-
 mice after transplantation of Id2
+/+
 bone marrow 
cells at indicated timepoints. SSC, Side scatter. Data shown are representative of at least n = 2 independent 
experiments. Scale bar 50µm. 
 
Mende et al. showed that Flt3+ progenitor cells in bone marrow contain LC precursors. 
However these studies were done under inflammatory conditions [192]. In order to 
characterize the Id2-dependent bone marrow LC precursor in steady state, Flt3+ 
progenitor cells that were described in chapter 3.1 were isolated, amplified in vitro and 
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used in reconstitution experiments of lethally irradiated Id2-/- mice. In vitro amplified Flt3+ 
progenitor cells repopulated MHC-II+ LCs in the epidermis of Id2-/- mice, although with 
slower kinetics compared to bone marrow cells (Figure 3-11, A and B). Additionally, 
kinetic studies showed a patchy distribution of emerging LCs, suggesting that LC 
repopulation might occur from immigrated precursors.  Comparable to the Id2+/+ bone 
marrow transplantation it took about two to three weeks for the cells to become positive 
for langerin (Figure 3-11 B). With respect to morphology and distribution, the newly 
emerged LCs were a little different from endogenous LCs of untreated mice. They appear 
slightly bigger, display more dendrites and express lower langerin, even 3 weeks after 
transfer, compared to LCs of untreated Id2+/+ mice. 
 
On the contrary, langerin+ dDCs could not be repopulated by transplantation of Id2+/+ 
Flt3+ progenitor cells (Figure 3-11 C). The population of CD45+ cells in dermis increased 
only three weeks after transplantation, but langerin+ dDCs could not be detected at any 
given time point (Figure 3-11 C). 
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Figure 3-11: Repopulation of skin DCs in Id2
-/-
 mice after adoptive transfer of Flt3
+
 progenitor cells. 
(A) Repopulation of LCs in Id2
-/-
 mice in epidermal sheets after transplantation of Id2
+/+
 Flt3
+
 progenitor 
cells. Epidermal sheets were stained for MHC-II (green) and DAPI (blue) 1 and 3 weeks after transplantation 
as indicated. (B and C) Flow cytometry of single-cell suspensions of epidermis (B) and dermis (C) from Id2
-/-
 
mice after transplantation of Id2
+/+
 Flt3
+
 progenitor cells at indicated timepoints; SSC, Side scatter. Data 
shown are representative of at least n = 2 independent experiments. 
 
These data clearly demonstrate that (i) the deficiency of LCs in Id2-/- mice results from 
impairment in the haematopoietic compartment, (ii) in adult mice LC precursors do not 
only exist in skin, but also in bone marrow and (iii) bone marrow Flt3+ progenitor cells can 
give rise to LCs under steady state conditions; although not langerin+ dDCs. 
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3.2.3 Id2
-/-
 Gr-1
hi
 monocytes infiltrate inflamed skin 
Previously, Ginhoux et al. [63] demonstrated that blood Gr-1hi monocytes are recruited to 
skin and develop into LCs under inflammatory conditions. To examine the possibility that 
LC deficiency in Id2-/- mice might be due to the absence of Gr-1hi monocytes as the 
potential circulating LC precursor in these mice, monocyte subsets in peripheral blood of 
Id2-/- and Id2+/+ mice were analyzed. Blood monocytes were identified as leukocytes with 
low side scatter profile that co-express CD11b and CD115, and were divided into two 
subpopulations according to their Gr-1 expression (Gr-1lo, Gr-1hi; Figure 3-12) [62]. 
Surprisingly, no significant differences in the Gr-1hi monocyte population were observed 
in Id2-/- mice compared to the corresponding WT littermates (Figure 3-12 B). 
 
Figure 3-12: Blood monocyte subsets in Id2
-/-
 mice. 
Monocyte subsets in peripheral blood from Id2
-/-
 and Id2
+/+
 mice were evaluated by flow cytometry. Cells 
were stained for CD115, CD11b, CD11c, and Gr-1. Monocytes were identified by low side scatter and co-
expression of CD115 and CD11b. (A) Subsets were defined by surface Gr-1 levels on CD115
+ 
CD11b
+
 
monocytes. (B) Distribution of CD115
+ 
CD11b
+
 monocytes and Gr-1 expression on monocytes in Id2
-/-
 (black) 
and Id2
+/+
 (open) mice. Data shown are representative of at least n = 7 independent experiments ± SD. n.s.= 
not significant. 
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Next it was analyzed whether Id2-/- Gr-1hi monocytes are capable of migrating into 
inflamed epidermis. Therefore, Gr-1hi monocytes were selectively labelled with 
fluorescent latex beads using an established protocol [62]. Approximately 7% of Gr-1hi 
monocytes in peripheral blood were found to be labelled with FITC-latex beads 24h after 
labelling and there was no difference seen for Id2-/- and Id2+/+ mice (Figure 3-13). 
 
Figure 3-13: Latex beads in peripheral blood monocytes 24h after injection. 
Gr-1
hi
 monocytes from Id2
-/-
 and Id2
+/+
 mice were labelled with FITC-conjugated latex-beads in vivo. The 
percentage of FITC-latex beads contained within monocytes is shown. SSC, Side scatter. Data shown are 
representative of at least n = 2 independent experiments. 
 
 
Labelling of Gr-1hi monocytes was followed by epicutaneous UV exposure as a stimulus 
for acute skin injury [83]. At day 5 after UV exposure epidermis and dermis were analyzed 
by flow cytometry for influx of FITC-latex bead-labelled Gr-1hi monocytes (Figure 3-14, A 
and B).  
A high influx of CD45+ cells at the site of inflammation for both Id2-/- and Id2+/+ mice was 
observed compared to steady state conditions (Figure 3-14, C and D). In epidermis the 
majority of infiltrating CD45+ cells was Gr-1hi expressing cells with a fraction being 
FITC-latex bead-positive Gr-1hi monocytes. The proportion of latex bead-positive and 
negative Gr-1hi monocytes was the same in both Id2-/- and Id2+/+ mice (Figure 3-14 A). 
Dermis of both Id2-/- and Id2+/+ mice also contained Gr-1hi and Gr-1lo cells with minor 
populations being latex bead-positive (Figure 3-14 B). In other parts of the body, where 
the skin was protected from UV light (i.e. at the trunk), no infiltration of CD45+ cells and 
no latex bead-positive cells were detected. Thus, Id2 is not required for development of 
the Gr-1hi monocytic LC precursor and its UV-induced migration into epidermis. 
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Figure 3-14: Influx of FITC-latex bead-labelled Gr-1
hi
 monocytes into inflamed skin of Id2
-/-
 mice. 
Gr-1
hi
 monocytes from Id2
-/-
 and Id2
+/+
 mice were labelled with FITC-conjugated latex-beads in vivo and 
exposed to UV light 4h later. Epidermis (A) and dermis (B) were examined 5 days after UV treatment for the 
presence of CD45
+
 cells and latex
+
 Gr-1
hi
 monocytes by flow cytometry. The percentage of FITC-latex bead-
labelled Gr-1
hi
 monocytes contained within CD45
+
 cells is shown. The fraction of latex
+
 Gr-1
hi
 monocytes 
corresponds to their labelling efficiency in blood. SSC, Side scatter. (C and D) The number of CD45
+
 cells as 
percentage of total epidermal (C) and dermal (D) cell numbers before (naïve; open) and 5 days after UV 
treatment (inflammation; black) in Id2
-/- 
and Id2
+/+
 mice. Data shown are representative of at least  
n = 3 independent experiments ± SD. *** p < 0.001. 
 
 
3.2.4 LC reconstitution after UV irradiation is Id2-independent 
So far, it could be shown that Gr-1hi monocytic LC precursors are present in Id2-/- mice at 
normal frequency and are recruited into epidermis upon UV exposure. Therefore, it was 
investigated whether LCs are repopulated in inflamed skin of Id2-/- mice. Id2-/- and Id2+/+ 
mice were exposed to UV light, and epidermis and dermis were analyzed 4 weeks later for 
the presence of LCs (Figure 3-15) and langerin+ dDCs (Figure 3-16).  
Flow cytometry analysis of single-cell suspensions revealed similar numbers of 
langerin+CD11c+ LCs in UV-treated Id2+/+ epidermis compared to untreated Id2+/+ mice 
(Figure 3-15 C), consistent with the de-novo LC differentiation from Gr-1hi monocytes 
following inflammation [63]. Remarkably, the epidermis of Id2-/- mice was also 
repopulated by langerin+CD11c+ LCs within 4 weeks after UV exposure (Figure 3-15). 
However, the frequency of CD45+ cells and LCs in Id2-/- epidermis was lower compared to 
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Id2+/+ mice, and langerin expression was diminished (Figure 3-15, A and B). Interestingly, 
langerin+ dDCs were not repopulated within 4 weeks after UV irradiation, although the 
entire population of CD11c+MHC-II+ dDCs was not altered in both Id2-/- and Id2+/+ mice 
(Figure 3-16). This indicates that Gr-1hi infiltrating monocytes serve as precursors for LCs, 
but not for langerin+ dDCs following skin injury. 
 
 
Figure 3-15: LC repopulation in epidermis in Id2
-/-
 mice after UV irradiation. 
Repopulation of LCs in epidermal sheets was examined by flow cytometry 4 weeks after UV irradiation. (A) 
Single-cell suspensions of epidermal sheets from Id2
-/-
 and Id2
+/+
 mice were examined for the presence of 
LCs (CD45
+
, CD11c
+
, and langerin
+
 cells). SSC, Side scatter. (B and C) Bar diagrams display the percentage of 
CD45
+
 cells in total cells (B) and the number of LCs in CD45
+
 cells (C) before (naïve; open) and 4 weeks after 
UV treatment (inflammation; black) in Id2
-/-
 and Id2
+/+
 mice. Data shown are representative of at least n = 3 
independent experiments ± SD. n.s. not significant; ** p < 0.01; *** p < 0.001. 
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Figure 3-16: Langerin
+
 dDC repopulation in dermis in Id2
-/-
 mice after UV irradiation. 
(A) Total dermal DCs and langerin
+
 DCs in dermal sheets of Id2
-/-
 and Id2
+/+
 mice were examined by staining 
for CD45, MHC-II, CD11c, and langerin. Total dDCs were defined as CD45
+
CD11c
+
 and MHC-II
+
. Langerin
+
 
dDCs were defined as CD45
+
CD11c
+
 and langerin
+
. SSC, Side scatter. (B to D) Bar diagrams show the 
frequency of CD45
+
 cells among total dermal cells (B), the frequency of DCs among CD45
+
 cells (C), and the 
frequency of langerin
+
 dDCs among total dDCs (D) before (naïve; open) and 4 weeks after UV treatment 
(inflammation; black) in Id2
-/-
 and Id2
+/+
 mice. Data shown are representative of at least n = 4 independent 
experiments ± SD. n.s. not significant; *** p < 0.001. 
 
3.2.5 LC maintenance after UV irradiation is Id2-dependent  
To investigate whether the monocyte derived LCs (mo-LCs) are capable of longterm 
repopulation of the epidermis, epidermal sheets of Id2-/- and Id2+/+ were analyzed 12 
weeks after UV treatment (Figure 3-17). 
Interestingly, epidermal sheets of Id2-/- mice were devoid of MHC-II+ and langerin+ LCs 12 
weeks after UV irradiation (Figure 3-17, A and B). The microscopic examination revealed 
no apparent differences in the LC compartment in Id2+/+ mice 12 weeks after UV exposure 
compared to untreated Id2+/+ mice (Figure 3-8 A and Figure 3-17 A). These data show that 
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Id2 is dispensable for mo-LC development under inflammatory conditions, but is an 
essential factor for steady state development of classical LCs in the epidermis. Moreover, 
it demonstrates that Gr-1hi monocytes give rise to only transient mo-LCs under 
inflammatory conditions.  
 
Figure 3-17: Longterm repopulation potential of LCs after UV irradiation. 
Longterm repopulation potential of LCs in epidermal sheets was examined by flow cytometry and 
fluorescence microscopy 12 weeks after UV irradiation. (A) Epidermal sheets from Id2
-/- 
and Id2
+/+
 mice 
were stained for MHC-II (green), langerin (red), and with DAPI (blue). (B) Single-cell suspensions of 
epidermal sheets from Id2
-/-
 and Id2
+/+
 mice were examined for the presence of LCs (CD45
+
, CD11c
+
, and 
langerin
+
 cells). SSC, Side scatter. Data shown are representative of at least n = 4 independent experiments. 
Scale bar 50µm. 
 
 
3.2.6 Reconstituted Id2
-/-
 LCs differ from Id2
+/+
 LCs  
So far the data indicated that inflammatory, Id2-independent mo-LCs may principally 
differ from steady state, Id2-dependent classical LCs. To assess morphology and 
distribution of LCs 4 weeks after UV exposure, epidermal sheets of Id2-/- and Id2+/+ mice 
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were double-stained with MHC-II and langerin specific antibodies. The emerging mo-LCs 
showed a patchy distribution as described before [63]. MHC-II+langerin+ LCs were 
observed in both Id2-/- and Id2+/+ mice (Figure 3-18 A). However, LC density was lower in 
Id2-/- mice compared to Id2+/+ mice, which is consistent with the data obtained by flow 
cytometry (Figure 3-15 A), and the re-evolved mo-LCs showed morphological differences 
compared to WT control (Figure 3-18 A). To analyze this observation in more detail 
epidermal sheets of Id2-/- and Id2+/+ mice were subjected to confocal laser-scanning 
microscopy. No apparent differences were observed for the expression of MHC-II in Id2-/- 
mo-LCs compared to Id2+/+ LCs (Figure 3-18 B). Conversely, langerin expression differed in 
Id2-/- and Id2+/+ LCs. Flow cytometry showed a diminished staining of langerin in Id2-/- mo-
LCs (Figure 3-15 A), whereas immunofluorescence data unveiled higher expression and 
dissimilar distribution of langerin in Id2-/- mo-LCs compared to Id2+/+ LCs (Figure 3-18 B). 
In Id2-/- mo-LCs MHC-II and langerin appear to be expressed all over the cell body, 
whereas in Id2+/+ LCs MHC-II and langerin are predominantly located to the perinuclear 
space (Figure 3-18 B), leading to the impression that Id2-/- mo-LCs appear larger than 
Id2+/+ LCs (Figure 3-18 A).  
Co-localization analysis of MHC-II and langerin expression also revealed different pattern 
in Id2-/- mo-LCs and Id2+/+ LCs. Id2+/+ LCs exhibit co-localization primarily within the 
perinuclear space. In contrast, Id2-/- mo-LCs display an almost complete overlap of MHC-II 
and langerin not only within the perinuclear space, but also in the periphery and 
dendrites (Figure 3-18, B and C). Additionally, this examination revealed that Id2-/- mo-LCs 
consistently have more dendrites compared to Id2+/+ LCs, while the entire cell dimensions 
were the same.  
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Figure 3-18: Phenotype of LC in Id2
-/-
 and Id2
+/+
 mice after UV irradiation. 
Morphology of LCs in epidermal sheets was examined by fluorescence and confocal microscopy 4 weeks 
after UV irradiation. Sheets were stained for MHC-II (green), langerin (red) and with DAPI (blue). (A) 
Fluorescence microscopy analysis of epidermal sheets from Id2
-/- 
and Id2
+/+
 mice. Scale bar, 50µm. (B and C) 
Confocal microscopy analysis of epidermal sheets from Id2
-/-
 and Id2
+/+
 mice. (B) Representative LCs from 
untreated Id2
+/+
 (upper panel), and Id2
+/+
 (middle panel) and Id2
-/- 
(lower panel) mice 4 weeks after UV 
irradiation. Scale bars, 20µm. (C) Superimposed z-stacks of LCs in Id2
-/-
 and Id2
+/+
 mice before and after UV 
treatment. Scale bars, 2µm. Data shown are representative of at least n = 4 independent experiments. 
 
Birbeck granules (BGs) are a hallmark of classical LCs. In order to extend the 
morphological examination for the presence of BGs in LCs after UV irradiation, epidermal 
sheets from Id2-/- and Id2+/+ mice were subjected to transmission electron microscopy. In 
epidermis from Id2+/+ mice BGs were found in all LCs analyzed and the frequency of LCs 
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was comparable to the frequency determined by flow cytometry (Figure 3-19). 
Conversely, in ultrathin sections of Id2-/- epidermis no LCs could be found, presumably 
due to the low mo-LC frequency, and thus analysis for BGs was not possible. 
 
Figure 3-19: Birbeck granules in epidermal LCs of Id2
-/-
 and Id2
+/+
 mice after UV irradiation. 
Electron micrographs of Id2
+/+
 ear skin epidermis 4 weeks after UV irradiation. Magnification in (I), 8.000 x. 
Scale bar, 2µm. SSp, Stratum spinosum; SGr, Stratum granulosum; N, nucleus; Mi, mitochondria; KF, keratin 
filaments; BG, Birbeck granules. Boxed area in (I) is represented in (II) with 220.000 x magnification. Scale 
bar, 100nm. CM, cell membranes; IS, intercellular space. Data shown are representative of at least n = 2 
independent experiments. 
 
 
3.2.7 Id2 is dispensable for in vitro LC development  
Flt3+ progenitor cells develop into LCs in vivo under steady state conditions (Figure 3-11). 
To investigate underlying molecular mechanisms of LC development, different in vitro 
culture systems were employed. Cultures of Id2+/+ and Id2-/- bone marrow cells with Flt3L 
gave cDCs and pDCs with the same efficiency, but langerin+ DCs were not detected (Figure 
3-20 A). When Flt3+ progenitor cells were generated and differentiated into DCs with GM-
CSF according to the two-step protocol [160], langerin+ DCs were obtained from both 
Id2+/+ and Id2-/- cultures, although at rather low frequency (Figure 3-20 B). 
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Figure 3-20: In vitro generation of LC-like cells in Flt3L and 2-step cultures from Id2
-/-
 and Id2
+/+
 mice. 
(A) Flt3L cultures were examined for the presence of pDCs and langerin
+
 DCs after 8 days of differentiation. 
pDCs from Flt3L cultures were first gated on CD11c
+
CD11b
-
 cells and display of PDCA-1 against Siglec H is 
shown (left panel). Langerin
+
 DCs were not detectable in Flt3L cultures at any time (right panel). (B) DCs 
from two-step cultures were first gated on CD11c
+
 cells. Staining for langerin against MHC-II is shown. Data 
shown are representative of at least n = 2 independent experiments. 
 
Finally, a DC culture system where DCs were generated directly from Id2+/+ and Id2-/- bone 
marrow with GM-CSF only was examined [161, 162].  After 8 days of culture DCs were 
analyzed for LC surface marker expression. Langerin+ DCs could be generated from both 
Id2+/+ and Id2-/- cultures and these cells expressed E-cadherin, Gr-1, F4/80, and CCR7 and 
thus resembled the phenotype of classical LCs in vivo (Figure 3-21) [26].  
This observation is in line with the previous findings that mo-LC development via the Gr-
1hi LC precursor occurs only under inflammatory conditions, but not in steady state. 
However, the percentage of MHC-II+langerin+ DCs in Id2-/- cultures was found to be three 
to four times lower compared to Id2+/+ cultures, which corresponds to the in vivo 
repopulation data (Figure 3-15). All this indicates that Id2 is not required for this 
inflammatory type of mo-LCs generated with GM-CSF in vitro. 
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Figure 3-21: In vitro generation of LC-like DCs from Id2
-/-
 and Id2
+/+
 mice. 
In vitro generated DCs were examined by flow cytometry after 8 days in culture. Single-cell suspensions 
from Id2
-/- 
and Id2
+/+ 
mice were examined for the presence of LCs by expression of CD11c, MHC-II, 
E-cadherin, langerin, Gr-1, and F4/80. SSC, Side scatter. Data shown are representative of at least n = 3 
independent experiments. 
 
The in vitro generated DCs from Id2+/+ and Id2-/- mice were further examined for the 
presence of BGs by transmission electron microscopy. BGs were found in DCs from both 
Id2+/+ and Id2-/- mice (Figure 3-22), revealing that Id2 is dispensable for BG formation in 
vitro. Noteworthy, only a fraction of the DCs contained BGs. 
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Figure 3-22: Birbeck granules in in vitro generated LC-like DCs from Id2
+/+
 and Id2
-/-
 mice. 
In vitro generated LC-like DCs containing BGs from bone marrow of Id2
+/+
 (I, III) and Id2
-/-
 (II, IV, V) mice. 
Scale bars in (I) and (II), 2µm. Boxed areas in (I) and (II) locating BGs in cells displayed at higher 
magnification in (III) and (IV), respectively.  Electron micrograph (V) shows a BG in another Id2
-/-
 DC sample. 
BGs in (III), (IV) and (V) are indicated by arrowheads. Scale bars in (III), (IV) and (V), 200nm. Data shown are 
representative of at least n = 2 independent experiments. 
 
In order to investigate the molecular mechanisms of langerin+ DC development in vitro, 
gene expression in Id2-/- and Id2+/+ bone marrow cultures was analyzed by RT-PCR.  
Expression of classical LC markers, such as CD11c, langerin, M-CSFR, and E-cadherin, 
members of the Id-family of HLH transcriptional regulators, and inflammatory chemokine 
receptors important for monocyte/ DC migration and maturation were investigated 
(Figure 3-23).  
 
Figure 3-23: Gene expression in LC-like DCs from Id2
-/-
 and Id2
+/+
 mice. 
RT-PCR analysis for indicated genes from in vitro generated bone marrow derived DCs of Id2
-/-
 and Id2
+/+
 
mice. HPRT was used as loading control. Data shown are representative of at least n = 3 independent 
experiments. 
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CD11c, langerin, E-cadherin, M-CSFR, CCR2, CCR4, CCR7, CCR9, and Id1 were expressed at 
similar levels in both Id2-/- and Id2+/+ cultures. Id4 was neither expressed in Id2-/- nor in 
Id2+/+ cells, and Id2 was only expressed in Id2+/+ cultures as expected.  Interestingly, Id3 
was highly expressed in Id2-/- cells, whereas the expression in Id2+/+ cells was low to 
absent. This finding suggests that the deficiency of Id2 might be compensated by Id3 in 
vitro. The substitution of Id2 by Id3 might be sufficient for an Id2 independent 
development of langerin+ DCs in vitro and presumably also for mo-LC development from 
Id2-/- Gr-1hi monocytes under inflammatory conditions in vivo.  
Results 66 
 
 
3.3 The influence of Id2 in lymphoid organ DC development  
In mice, secondary lymphoid organs include spleen, thymus, lymph nodes, mucosal-
associated lymphoid tissues, such as nasal-associated lymphoid tissue (NALT), and Peyer’s 
patches, as well as other gut-associated lymphoid tissue [193].  
The spleen is the main organ used for studies of immunity in mice. During steady-state 
four functionally distinct DC subsets can be defined [53]. These include the circulating 
plasmacytoid DCs (pDCs), and the three subsets of tissue resident cDCs. It was believed 
that  CD8α- cDCs are located in the marginal zone, whereas the CD8α+ cDCs are localized 
to T cell areas [24, 48, 194, 195]. However, recent studies by Idoyaga et al. found that 
large numbers of CD8α+CD207+ cDCs are located in the marginal zone, with smaller 
numbers in red pulp and the T cell area [195]. 
 
Thymic cDCs are mainly lymphoid organ resident cDCs. In contrast to the spleen, most 
mouse thymic cDCs are of the CD8α+ subtype, with only a minority population that is 
similar to double negative cDCs and few if any cDCs that express CD4 [196]. The thymic 
CD8α+ cDCs are generated within the thymus from the earliest intrathymic progenitors, 
whereas the minor CD8α- cDCs originate from peripheral migratory DCs [53, 66, 165, 166, 
197]. 
 
DCs show more developmental flexibility at early stages of haematopoiesis than other 
blood cell lineages. However, the developmental origin of these DC subtypes and their 
relationship has been controversial. Cell kinetic studies indicate that, at some point, the 
lineages leading to the different cDC subtypes branch and develop independently [67]. 
This is supported by studies showing that different transcription factors are required for 
the development of the different DC subtypes [139, 142, 156, 157]. 
 
Mice deficient in Id2 have undetectable lymphoid tissue inducer cells (LTi cells), which 
produce lymphotoxin. Lymphotoxin is essential for secondary lymphoid organ 
development and Id2-/- mice lack lymph nodes, Peyer’s patches, and NALT [193].  
This section investigates the influence of Id2 in DC development in lymphoid organs. 
Furthermore it analyses whether other lymphocytes, especially T cells, are also affected 
by the Id2 deficiency. 
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3.3.1 Id2 deficiency results in decreased cDC numbers in spleen 
As already shown, Id2 deficient mice suffer from alymphoplasia (Figure 3-24 A), and lack 
Peyer’s patches. Moreover, they show minor signs of splenomegaly (Figure 3-24 B), 
although splenic architecture is normal [198]. Conversely, the thymus of Id2-/- mice 
appeared completely normal in size and structure [198].   
 
Figure 3-24: Id2 deficiency results in lack of lymph nodes and enlarged spleen. 
(A) The inguinal region; a lymph node is evident in the Id2
+/+
 mouse (left) but missing in the Id2
-/-
 mouse 
(right). (B) Comparison of Id2
-/-
 (upper) and Id2
+/+
 (lower) spleen. The slight enlargement of the Id2
-/-
 spleen 
is easily visible. Data shown are representative of at least n = 10 independent experiments. 
 
In addition, previous characterization of Id2-/- mice demonstrated that Id2 was crucial for 
the development of distinct DC subsets as the splenic CD8α+ DCs, which are severely 
reduced in these mice [156]. Therefore, DCs from Id2-/- and Id2+/+ spleen were prepared 
and analyzed by flow cytometry. In Id2-/- mice the percentage of total DCs, determined by 
MHC-II and CD11c, was found to be reduced by half compared to Id2+/+ mice (Figure 
3-25). 
Furthermore, flow cytometry analysis demonstrated a marked reduction in CD8α+ cDCs in 
spleen, confirming previous studies (Figure 3-25). Thus, deletion of Id2 resulted in a 
severe shift in the proportion of splenic cDC subsets; CD4-CD8α+ DCs were markedly 
reduced, and therefore CD4+CD8α- DCs were the predominant DC population in spleen 
(Figure 3-25). 
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Figure 3-25: Id2 deficiency results in decreased DC numbers in spleen. 
Dendritic cells were determined as CD45
+
 cells low in side scatter and double positive for MHC-II and CD11c. 
Distribution of CD4
+
 versus CD8α
+
 DCs is shown (A). Bar diagrams represent the percentage of total DCs (B), 
CD4
+
 DCs (C), and CD8α
+
 DCs (D) in spleen of Id2
-/-
 (black) and Id2
+/+
 (open) mice. Data shown are 
representative of at least n = 10 independent experiments ± SD; *** p < 0.001. 
 
 
3.3.2 Id2 mice lack CD8α
+
 and CD8α
+
langerin
+
 DCs in spleen and thymus 
Recent studies reported on a subset of CD8a+ cDCs that is located to the marginal zone 
rather than to the T cell area and also expresses langerin [195]. Hence, spleen DCs were 
further analysed for this CD8α+langerin+ subpopulation. In Id2+/+ mice CD8α+langerin+ 
cDCs were easily detected and they made up for about 40% of the CD8α+ cDC population 
in spleen (Figure 3-26). However these cells, as well as the CD8α+ DC subpopulation, were 
virtually absent in Id2-/- mice (Figure 3-26, A and B). 
This analysis was expanded to the thymus, where langerin+ DCs can also be found. Flow 
cytometry revealed no differences in the DC compartment in Id2-/- and Id2+/+ mice (Figure 
3-26 D). Moreover, CD8α+ cDCs were present in Id2-/- mice at normal frequency compared 
to WT control. However, the CD8α+langerin+ DC subset was only found in Id2+/+ mice and 
was absent in Id2-/- mice (Figure 3-26, C and E). 
Interestingly, in thymus of Id2-/- mice CD8α+ cDCs are still present and develop in the 
absence of Id2, implying a differential requirement for Id2 in DC development in bone 
marrow or thymus. 
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Figure 3-26: CD8α+langerin+ cDC subsets in spleen and thymus of Id2-/- and Id2+/+ mice. 
Dendritic cells were determined as CD45
+
 cells low in side scatter, double positive for MHC-II and CD11c. (A) 
Distribution of langerin versus CD8α
+
 in spleen DCs. (B) Bar diagram representing the percentage of 
CD8α
+
langerin
+
 DCs in total spleen DCs of Id2
-/-
 (black) and Id2
+/+
 (open) mice. (C) Distribution of langerin 
and CD8α on thymus DCs. (D and E) Bar diagrams represent the fraction of total DCs in thymus (D) and of 
CD8α
+
langerin
+
 DCs within total thymic DCs (E) in Id2
-/-
 (black) and Id2
+/+
 (open) mice. Data shown are 
representative of at least n = 5 independent experiments ± SD; n.s. not significant; *** p < 0.001. 
 
 
3.3.3 Rescue of Id2
-/-
 phenotype by adoptive transfer 
As already described, the in vitro amplified Flt3+ progenitors have the capacity to 
differentiate into all cells of the haematopoietic system upon cell transfer (section 3.1.4) 
and it was further demonstrated that this progenitor is able to give rise to both splenic 
CD8α+ and CD8α- DCs in vivo [160]. Thus, Id2+/+ bone marrow cells or in vitro amplified 
Flt3+ progenitor cells from Id2+/+ mice, together with a radioprotective dose of Id2-/- bone 
marrow to assure mouse survival, were transferred into lethally irradiated Id2-/- recipient 
mice. Spleen and thymus of recipients were analyzed for CD8α+ and CD8α+langerin+ cDCs 
two weeks after cell transfer, because previous studies showed that CD8α+ DCs reach 
their peak two weeks after bone marrow transfer [73]. 
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CD8α+ as well as CD8α+langerin+ DCs could be detected in spleen of Id2-/- mice two weeks 
after bone marrow transplantation (Figure 3-27 A). However, the proportion of each 
splenic DC population generated by bone marrow transplantation did not match the 
proportions found in the normal mouse spleen (Figure 3-25). This is not achieved until 
four to eight weeks after bone marrow transfer [67]. The transplantation of Flt3+ 
progenitor cells also resulted in a repopulation of CD8α+ DCs in spleen, confirming 
previous data [160]. Still, CD8α+langerin+ DCs were not detectable two weeks after 
transplantation (Figure 3-27 B). Analysis of the thymus two weeks after cell transfer 
revealed similar data. Whereas transfer of bone marrow cells repopulated CD8α+langerin+ 
cDCs in thymus, these cells remained absent after transplantation of Flt3+ progenitor cells 
(Figure 3-27 C). 
 
Figure 3-27: Adoptive transfer of bone marrow or Flt3
+
 progenitor cells rescues Id2
-/-
 phenotype 
Id2
+/+
 bone marrow cells or in vitro amplified Flt3
+
 progenitor cells from Id2
+/+
 mice, together with a 
radioprotective dose of Id2
-/-
 bone marrow to assure mouse survival, were used for adoptive transfer 
experiments. Single-cell suspensions from spleen (A and B) and thymus (C) were analysed two weeks after 
transfer of unfractionated bone marrow cells (A) or Flt3
+
 progenitor cells (B) for the presence of CD8α
+ 
and 
CD8α
+
langerin
+
 DCs respectively. Data shown are representative of at least n = 5 independent experiments. 
 
 
3.3.4 Id2 deficiency leads to increased pDCs 
The pDCs have many features that indicate they should arise from a developmental 
pathway that differs from that of cDCs [199]. In terms of gene expression, pDCs have 
many similarities to B cells and their development depends on the transcription factor 
SPI-B, which is also expressed by B cells but not by cDCs [52, 54]. Nevertheless, pDCs can 
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be produced from the same bone marrow precursors that give rise to cDCs [81, 82], they 
also depend on FLT3L for their production [93, 154], and their development involves 
many of the same transcription factors that are required for particular cDC subtypes. 
The pDCs in spleen were defined as low side scatter cells positive for CD45 being 
CD11c+CD11b-B220+PDCA-1+SiglecH+ and B cells were determined as low side scatter 
CD45+ cells double positive for B220 and CD19. Comparison of single cell suspensions 
from spleen of Id2-/- and Id2+/+ mice demonstrated that pDCs were increased by about 
two-fold (Figure 3-28, A and B). Conversely, the B cell population was not affected by the 
Id2 deficiency and remained stable (Figure 3-28, C and D). 
 
Figure 3-28: Increased pDCs in Id2
-/-
 mice 
Low side scatter CD45
+
 cells of single-cell suspensions of Id2
-/-
 and Id2
+/+
 spleens were analysed for pDCs (A 
and B) and B cells (C and D). pDCs were gated on CD45
+
CD11c
+
CD11b
-
 and the staining for PDCA-1 versus 
Siglec H and for B220 are shown (A). The percentage of pDCs in splenic CD45
+
 cells of Id2
-/-
 (black) and Id2
+/+
 
(open) mice is depicted as bar diagram (B). B cells were defined as CD45
+
 cells low in side scatter and double 
positive for B220 and CD19 (C) and their frequency in CD45
+
 cells of Id2
-/-
 (black) and Id2
+/+
 (open) mice is 
represented as bar diagram (D). Data shown are representative of at least n = 6 independent experiments ± 
SD; n.s. not significant; *** p < 0.001. 
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3.3.5 Id2 is essential for CD8 T cell maintenance in spleen and thymus 
As shown here, Id2-/- mice displayed a selective and remarkable reduction of the CD8α+ 
DC subset. The CD8α+ DCs effectively prime naive CD4+ T cells and preferentially induce 
TH1 differentiation in vivo [200]. To investigate whether the Id2 deficiency influences the 
T cell compartment, spleen and thymus of Id2-/- and Id2+/+ mice were analysed by flow 
cytometry (Figure 3-29). T cells were defined as CD45+ cells low in side scatter, expressing 
CD3ε and further separated according to their distribution of CD4 and CD8α (Figure 3-29). 
Analysis of splenocytes revealed comparable numbers of CD3ε+ T cells in both Id2-/- and 
Id2+/+ mice (Figure 3-29, A and B). However, the examination of T cell subsets showed a 
distinct shift in the CD4/CD8 ratio in Id2-/- mice. The CD4+ T cell population increased from 
60% in Id2+/+ mice to 85% in Id2-/- mice. Conversely, the CD8+ T cell population decreased 
from 30% in Id2+/+ mice to 10% in Id2-/- mice (Figure 3-29, A and C). Analysis of the thymus 
revealed similar data as the results from spleen. The number of total T cells was similar in 
Id2-/- and Id2+/+ mice (Figure 3-29, D and E), whereas the ratio of CD4+ versus CD8+ T cells 
was changed in Id2-/- mice. However, in thymus only the CD8+ T cell population was 
decreased compared to Id2+/+ mice, CD4+ and double positive T cells remained unchanged 
(Figure 3-29, D and F). These results suggest that Id2 is profoundly involved in the 
development or survival of CD8+ T cells.  
Results 73 
 
 
 
Figure 3-29: Altered T cell ratios in Id2
-/-
 mice. 
(A to C) Splenocytes of Id2
-/-
 and Id2
+/+
 mice were analysed for their T cell compartment. T cells were 
determined as CD45
+
 cells low in side scatter and positive for CD3ε and the distribution of CD4 versus CD8 is 
shown (A). The bar diagrams show the percentage of total T cells among splenocytes (B) and the 
distribution of CD4
+
 and CD8
+
 T cells among total T cells (C) in Id2
-/-
 (black) and Id2
+/+
 (open) mice. (D to F) 
Thymocytes of Id2
-/-
 and Id2
+/+
 mice were analysed for their T cell compartment. T cells were determined as 
CD45
+
 cells low in side scatter and positive for CD3ε and the distribution of CD4 versus CD8 is shown (D). 
The bar diagrams show the percentage of total T cells among thymocytes (E) and the distribution on CD4
+
 
and CD8
+
 T cells among total T cells (F) in Id2
-/-
 (black) and Id2
+/+
 (open) mice. Data shown are 
representative of at least n = 4 independent experiments ± SD; n.s. not significant; *** p < 0.001. 
Results 74 
 
 
3.4 Id2 antagonizes the function of activating bHLH proteins 
The E protein family of transcription factors and their natural inhibitors, the “inhibitor of 
DNA binding” (Id) proteins, regulate many aspects of haematopoiesis, including 
commitment to the lymphoid lineages at several developmental stages [201, 202]. E 
proteins are a subclass of the basic helix-loop-helix family of transcriptional activators and 
repressors consisting of HEB, E2-2, and the E2A gene products, which bind specifically to 
DNA sequences containing the E-box consensus sequence. DNA binding by E proteins is 
regulated by the Id proteins, a family of highly related gene products. Id  proteins, of 
which four (Id1–4) have been identified, contain the helix-loop-helix domain necessary for 
the formation of dimers, but lack the basic region that mediates DNA binding [201, 202]. 
Thus, Id proteins form heterodimers with E proteins and thereby prevent their association 
with E box motifs in target DNA sequences (Figure 3-30) [202-204]. 
 
 
Figure 3-30: The antagonism of E2A and Id2.  
(A) E2A forms homo- or heterodimer with other activating bHLH transcription factors, resulting in its 
binding to E-box sequences in target DNA. (B) When Id2 is present it binds to E2A and thereby preventing 
the complex from binding to DNA, resulting in inhibition of transcription. 
 
The E proteins encoded by the E2A gene, E12 and E47, are known to be essential for 
development of committed B lymphocyte progenitors from CLPs as a result of their role in 
the induction of the B lineage transcription factor early B cell factor (EBF) and subsequent 
activation of Pax-5, which commits cells to the B lymphocyte lineage [204].  
Therefore, an attractive hypothesis for the role of Id2 in DC development is that Id2 
functions to inhibit E protein activity, allowing these cells to adopt non–B lineage cell 
fates by preventing B lymphocyte lineage commitment [157, 205]. However, Id2 has been 
proposed to have targets in addition to E proteins that could function in DC development, 
including the Ets family proteins PU.1 and the retinoblastoma protein [206, 207].  
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This section examines the question to what extend the antagonism of Id2 and E2A is 
required for the development of DC subsets, in particular for skin DCs. Furthermore, 
questions whether lowering E protein activity in Id2-/- mice by deletion of the E2A gene 
product E47 results in the restoration of previously absent DC subtypes.  
 
 
3.4.1 E47 deletion overcomes the need for Id2 in the development of langerin
+
 skin 
DCs 
Besides its known regulatory function in B cell development, Id2 is essential for the 
development of natural killer cells (NKs), LTi cells, and secondary lymphoid tissues. 
However, a recent study by Boos et al. reports that the deletion of the E protein E47 in 
Id2-/- mice results in the restoration of NK cells and LTi cells in the embryo, as well as the 
restoration of lymph nodes and Peyer’s Patches [208]. Therefore, DC subsets in E47+/-
Id2+/- (dhet), E47-/-Id2+/- (E47ko), E47+/-Id2-/- (Id2ko), and E47-/-Id2-/- (dko) mice were 
investigated, especially those that are absent in Id2-/- mice. 
 
As reported in section 3.2, Id2-/- mice lack LCs in the epidermis as well as a langerin 
expressing subpopulation of DCs in dermis (Figure 3-8). To analyse the importance of the 
antagonism of Id2 and its counterpart E2A for the development of skin DCs flow 
cytometry analysis of single cell suspensions of epidermis and dermis of  dhet, E47ko, 
Id2ko, and dko mice was performed (Figure 3-31). This revealed that LCs, characterized by 
CD45, CD11c, MHC-II and langerin expression, were present in epidermis of dhet and 
E47ko mice as expected. Importantly, LCs were also detected in epidermis of dko mice, 
whereas these cells were absent in Id2ko mice (Figure 3-31). Furthermore, the flow 
cytometry data showed that the deficiency of E47 and Id2 not only restored the LC 
compartment in these mice, but also restored parts of the CD45+ cell population in the 
epidermis (Figure 3-31, A and B). 
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Figure 3-31: E47 deficiency overcomes the need for Id2 in LC development 
(A) Flow cytometry of single-cell suspensions of epidermis from dhet, E47
ko
, Id2
ko
, and dko mice. For 
detection of LCs, cells from epidermal sheets were stained for CD45, CD11c, and langerin; SSC, Side scatter. 
(B) Frequency of CD45
+
 cells among total epidermal cells and (C) frequency of LCs among CD45
+
 cells in dhet 
(open), E47
ko
 (light grey), Id2
ko
 (grey), and dko (black) mice. Data shown are representative of at least n = 2 
independent experiments ± SD. ** p < 0.01; *** p < 0.001. 
 
Flow cytometry of dermis of dhet, E47ko, Id2ko, and dko mice demonstrated that CD45+ 
cell frequency was comparable in dhet, and E47ko mice, but were decreased in Id2ko mice, 
similar to Id2-/- mice. The leukocyte reduction seen in Id2ko mice was not restored in dko 
mice, but remained dimished as in Id2-/- mice (Figure 3-32, A and B). Interestingly, the 
total DC number in dermis was also decreased in Id2ko mice, a phenotype not found in 
Id2-/- mice (Figure 3-9). The reduction in DC numbers was also not restored in dko mice 
and remained similar to the frequency observed in Id2ko mice (Figure 3-32 C). 
 
Nevertheless, langerin+ dDCs characterized by CD11c, MHC-II, and langerin were found in 
dhet, E47ko, and dko mice, but absent in Id2ko mice as expected (Figure 3-32, A lower 
panel and D). The frequency was comparable to that of dhet and E47ko mice. 
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Figure 3-32: The deficiency of E47 and Id2 rescues langerin
+
 dDCs 
(A) Langerin
+
 dDCs from dhet, E47
ko
, Id2
ko
, and dko mice were identified by staining for CD45, CD11c, and 
langerin; SSC, Side scatter. (B to D) Frequency of CD45
+
 cells among total dermal cells (B), frequency of DCs 
among CD45
+
 cells (C), and frequency of langerin
+
 dDCs among total dDCs (D) in dhet (open), E47
ko
 (light 
grey), Id2
ko
 (grey), and dko (black) mice. Data shown are representative of at least n = 2 independent 
experiments ± SD. n.s. not significant; * p < 0.05; *** p < 0.001. 
 
 
3.4.2 The double-deficiency of Id2 and E47 does not restore the Id2
-/-
 phenotype in 
spleen DCs 
Next, the impact of Id2 and E47 were analysed in spleen DCs as the data in section 3.3 
demonstrate that Id2 has a strong influence on the development of certain subsets 
(Figure 3-25). Therefore, DCs from dhet, E47ko, Id2ko, and dko spleen were analyzed by 
flow cytometry for the different subsets. In Id2-/- mice the percentage of total DCs, 
determined by MHC-II and CD11c was found to be reduced by half compared to Id2+/+ 
mice (Figure 3-25). This observation was similar for Id2ko and dhet mice; Id2ko mice 
showed a reduction in spleen DCs of about 50% compared to dhet mice (Figure 3-33, A 
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and B). Furthermore, flow cytometry analysis demonstrated an increase of DCs in E47ko 
and dko mice, which most probably results from the lack of B cells in E47 deficient mice. 
However, the increase in splenic DCs in E47ko and dko mice is not statistically significant 
when compared to dhet mice. Because deficiency of both Id2 as well as E2A results in 
severe difficulties during pregnancy, breeding of the E47Id2 mice resulted only in very 
few pups. Hence, statistical analysis in these mice is difficult. Therefore, the “normal” 
frequency in splenic DCs of dko mice rather due to the complete absence of B cells in 
mice deficient for E47 and the consequent shift in cells ratios than a regeneration of the 
DC population. 
 
Further analysis of cDC subsets demonstrated a marked reduction in splenic CD8α+ cDCs 
in Id2ko and dko mice as already seen in Id2-/- mice (Figure 3-25, A and D; and Figure 3-33, 
A and D). This lack of CD8α+ cDCs resulted in a subsequent increase in percentage of CD4+ 
cDCs in mice lacking Id2 (Figure 3-25 C and Figure 3-33 C). The proportion of CD4+ and 
CD8α+ cDCs in dhet and E47ko mice was comparable, demonstrating that E47 deficiency 
has no influence on the development of these DC subsets. Nevertheless, the fact that 
CD8α+ cDCs are not restored in spleen of dko mice suggests a role for Id2 in suppression 
of alternative E proteins.  
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Figure 3-33: CD8α+ cDCs remain absent in dko mice. 
DCs of dhet, E47
ko
, Id2
ko
, and dko mice were determined as CD45
+
 cells low in side scatter and double 
positive for MHC-II and CD11c. Distribution of CD4
+
 versus CD8α
+
 DCs is shown (A). Bar diagrams represent 
the percentage of total DCs (B), CD4
+
 DCs (C), and CD8α
+
 DCs (D) in spleen of dhet (open), E47
ko
 (light grey), 
Id2
ko
 (grey), and dko (black) mice. Data shown are representative of at least n = 2 independent experiments 
± SD; n.s. not significant; ** p < 0.01. 
 
 
3.4.3 Loss of E47 fails to restore CD8α+langerin+ cDCs spleen or thymus of Id2-/- mice 
As already reported in section 3.3, both spleen and thymus contain a small subset of cDCs 
that expresses CD8α as well as langerin. Hence, the analysis of DC subsets was broadened 
to langerin+ DCs in spleen and thymus. CD8α+langerin+ cDCs were easily detected in 
spleen and thymus of dhet and E47ko mice, but absent in Id2ko mice, as already seen for 
Id2-/- mice (Figure 3-34 and Figure 3-26). There was no difference seen in the langerin+ 
population between dhet and E47ko mice. Interestingly, in contrast to splenic DCs, the 
number of thymic DCs remained stable in all mice, regardless of their genotype. No 
differences were seen for CD8α+ cDCs among dhet, E47ko, Id2ko, and dko mice, similar to 
the observation in section 3.3 (Figure 3-34 and Figure 3-26, C to E). However, langerin+ 
cDCs were virtually absent in spleen and thymus of Id2ko and dko mice, supporting the 
data in section 3.3 (Figure 3-34 and Figure 3-26).  
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Figure 3-34: CD8α+langerin+ cDCs cannot be found in spleen or thymus of dko mice. 
DCs of dhet, E47
ko
, Id2
ko
 , and dko mice were determined as CD45
+
 cells low in side scatter, double positive 
for MHC-II and CD11c. (A) Distribution of langerin versus CD8α
+
 in spleen DCs. (B) Distribution of langerin 
and CD8α on thymus DCs. (C) Bar diagram representing the percentage of CD8α
+
langerin
+
 DCs in total 
spleen DCs. (D and E) Bar diagrams represent the fraction of total DCs in thymus (D) and of CD8α
+
langerin
+
 
DCs within total thymic DCs (E) of dhet (open), E47
ko
 (light grey), Id2
ko
 (grey), and dko (black) mice. Data 
shown are representative of at least n = 2 independent experiments ± SD; n.s. not significant. 
 
3.4.4 Only E47
-/-
Id2
-/-
 double deficiency leads to increased pDCs 
Section 3.3 demonstrated that the deficiency of Id2 resulted in an increased frequency of 
pDCs in spleen, whereas the B cell population remained unchanged (Figure 3-28). 
Moreover, specific functions of the E2A proteins have been most extensively studied in 
the context of B lineage development, which is completely blocked at a stage preceding 
the onset of immunoglobulin gene rearrangement in E2A-deficient mice and therefore 
are a good example for the crosstalk of HLH transcription factors/ regulators during 
development [204, 205].  
 
The pDCs and B cells in spleen were analysed by flow cytometry as defined in section 3.3. 
Comparison of single cell suspensions from spleen of dhet, E47ko, Id2ko, and dko mice 
demonstrated that pDCs were not changed in dhet, E47ko, and Id2ko mice, only in dko 
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mice an increase in pDCs could be observed (Figure 3-35, A and C). This differs from the 
data obtained in section 3.3, where an increase in pDCs was already observed in Id2-/- 
mice. This discrepancy might arise from the different background of these mice. However, 
taken into account that breeding resulted only in very few mice and statistical analysis 
was not possible in this case, it might be that these data do not represent in vivo 
conditions.  
Conversely, the B cell population was completely absent in mice that were deficient in 
E47, which is consistent with current literature. In dhet and Id2ko mice B cells were not 
affected, supporting the data of Id2+/+ and Id2-/- mice in section 3.3, indicating that the 
role of Id2 is negligible for B cell development (Figure 3-35, B and C; Figure 3-28, C and D). 
 
Figure 3-35: Increased pDCs in dko mice. 
Low side scatter CD45
+
 cells in spleens of dhet, E47
ko
, Id2
ko
, and dko mice were analysed for pDCs (A) and B 
cells (B). pDCs were gated on CD45
+
CD11c
+
CD11b
-
 and the stainings for PDCA-1 versus SiglecH and for B220 
are shown. The percentage of pDCs in CD45
+
CD11b
-
 cells (C) and the percentage of B cells (D) among low 
side scatter CD45
+
 cells of dhet (open), E47
ko
 (light grey), Id2
ko
 (grey), and dko (black) mice are depicted as 
bar diagrams. Data shown are representative of at least n = 1 independent experiments ± SD. 
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3.4.5 Id2 remains essential for CD8
+
 T cell maintenance in spleen and thymus 
As shown in section 3.3, Id2-/- mice displayed a selective and remarkable reduction of the 
CD8+ T cell subset. To investigate whether the antagonism of E47 and Id2 influences T cell 
development, spleen and thymus of dhet, E47ko, Id2ko, and dko mice were analysed by 
flow cytometry (Figure 3-36 and Figure 3-37). T cells were defined as described in section 
3.3 and the analysis of splenocytes revealed an increase of CD3ε+ T cells in E47ko and dko 
mice. Again, this apparent increase in T cells results from the lack of B cells, caused by the 
E47 deficiency (Figure 3-36, A and B). Further analysis of T cell subsets showed the 
distinct shift in the CD4/CD8 ratio in Id2ko and dko mice, already seen in Id2-/- mice in 
section 3.3 (Figure 3-36). The increase in the CD4+ T cell population and simultaneous 
decrease in CD8+ T cells was only seen in those mice lacking Id2 and remained unchanged 
in dhet and E47ko mice. However, in dko mice a partial reconstitution of the CD8+ T cell 
population could be observed, indicating a responsibility of Id2 for T cell maintenance 
(Figure 3-36, A and D). 
 
Figure 3-36: Id2 remains essential for CD8
+
 T cell maintenance in spleen of  dko mice. 
(A) Splenocytes of dhet, E47
ko
, Id2
ko
, and dko mice were analysed for their T cell compartment. T cells were 
determined as low side scatter CD45
+
 cells positive for CD3ε and the distribution of CD4 versus CD8 is 
shown (A, lower panel). The bar diagrams show the percentage of total T cells among splenocytes (B), the 
distribution of CD4
+
 T cells among total T cells (C), and the distribution of CD8
+
 T cells among total T cells (D) 
in dhet (open), E47
ko
 (light grey), Id2
ko
 (grey), and dko (black) mice. Data shown are representative of at 
least n = 2 independent experiments ± SD; n.s. not significant; * p < 0.05; *** p < 0.001. 
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Analysis of thymii of dhet, E47ko, Id2ko, and dko mice revealed similar data as seen in 
section 3.3. The number of CD3ε+ T cells was comparable in dhet, E47ko, Id2ko, and dko 
mice (Figure 3-37, A and B). Investigations of T cell subsets showed a mild increase in 
CD4+ T cells in Id2ko, and dko mice compared to dhet mice (Figure 3-37, A and C). 
Furthermore, the analysis demonstrated a reduction of CD8+ T cells in those mice that 
were deficient in Id2, but unchanged frequency in dhet and E47ko mice. These data are 
comparable to the results obtained from thymii of Id2-/- and Id2+/+ mice and can be 
ascribed to the Id2 deficiency, indicating an essential role for Id2 in CD8+ T cell 
maintenance (Figure 3-37, A and D). The population of CD4+CD8+ T cells remained 
unchanged in dhet, E47ko, Id2ko, and dko mice (Figure 3-37, A and E). 
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Figure 3-37: E47 deficiency in Id2
-/-
 mice does not rescue the Id2
-/-
 phenotype in thymic T cells 
(A to E) Thymocytes of dhet, E47
ko
, Id2
ko
, and dko mice were analysed for their T cell compartment. T cells 
were determined as CD45
+
 cells low in side scatter and positive for CD3ε and the distribution of CD4 versus 
CD8 is shown (A). The bar diagrams show the percentage of total T cells among thymic CD45
+
 cells (B), the 
distribution of CD4
+
 T cells among total T cells (C), the distribution of CD8
+
 T cells among total T cells (D), 
and the distribution of CD4
+
CD8
+
 T cells among total T cells (E) in dhet (open), E47
ko
 (light grey), Id2
ko
 (grey), 
and dko (black) mice. Data shown are representative of at least n = 2 independent experiments ± SD; n.s. 
not significant. 
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4 Discussion 
By now it is evident that DCs are not a homogeneous population, but a group of discrete 
subpopulations. They share several features, but also differ in their location, their 
functional properties, and their origin. Because of this diversity and their rare frequency 
in steady state detailed examination of DC development remained difficult. Although a lot 
of effort has been made over the last years, the final steps in DC development and the 
underlying mechanisms are still elusive. Nevertheless, several studies have recently 
reported on the existence of different DC precursors, either from bone marrow or locally 
developing in lymphoid tissue [209-211]. To what extent these precursors overlap or 
emerge from each other requires further examination. 
 
4.1 Characterization of an in vitro amplified Flt3
+
precursor 
The previously described Flt3+ progenitor is also a precursor for DCs, although placed 
earlier in haematopoiesis than the above mentioned progenitors, as it is not restricted to 
the DC lineage [160, 168]. This progenitor was already determined to give rise to CD8α+ 
and CD8α- DCs in vivo as well as to CD11c+CD11b+ DCs in vitro, demonstrating its potential 
to develop into different types of DCs. Because of the results by Nagai et al., indicating 
that undifferentiated progenitor cells can distinguish ‘‘non-self’’ from ‘‘self’’ via TLRs and 
that microbial components could be cues for haematopoietic cell development [176], the 
Flt3+ progenitor was examined for its TLR repertoire in vitro. All TLRs, except TLR11, were 
found to be expressed in Flt3+ precursors on mRNA levels. Furthermore, flow cytometry 
analysis showed that TLRs 1 to 7 and TLR9 are expressed on protein levels as well. This 
expression was further upregulated when the Flt3+ precursors were differentiated into 
CD11c+CD11b+ DCs in vitro. 
 
TLR signalling normally results in the secretion of cytokines and chemokines to initiate an 
immune response. Within the context of HSCs and progenitor cells, such signals may help 
to replace and/or increase cells that constitute a first line of defence against pathogens. 
Interestingly, stimulation of Flt3+ precursor cells with various TLR ligands did not result in 
the secretion of cytokines. Conversely, DCs differentiated from the Flt3+ progenitor by 
GM-CSF did respond effectively to all TLR ligands used in the experiments by secreting IL-
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6, IL-10, IL-12p70, MCP-1, MIG, and TNFα. The lack of cytokine secretion from the Flt3+ 
precursor cells might be due to non-functional TLRs or to non-functional signalling 
cascades. Although TLR stimulation does not result in an immune response in the Flt3+ 
precursor, the possibility that TLR signalling might have an influence on lineage decision 
cannot be excluded. Another possibility is that TLR signalling in the Flt3+ precursor might 
be inhibited by dexamethasone, which is present during the amplification phase of the 
two-step culture. Dexamethasone is described to inhibit NFκB activity and to reduce the 
functionality of IRF3, which are both essential components in the TLR signalling cascades 
[212].  
This project was continued within the diploma thesis of Julia Pabich. For further analysis 
of TLR signalling in the Flt3+ precursor in vitro and in vivo and the influence of 
dexamethasone, please refer to her diploma thesis. 
 
Furthermore, these data demonstrate that DCs differentiated with GM-CSF are not 
limited in their response to TLR stimulation and that they produce Th1 as well as Th2 
cytokines. However, this is most probably not representing a steady state situation in vivo 
as GM-CSF levels are almost undetectable during steady state and GM-CSF deficient mice 
display normal levels of DCs [89, 90]. However, GM-CSF levels increase in vivo during 
inflammation, resulting in the appearance of an additional DC type, so called 
inflammatory DCs [92, 213]. These inflammatory DCs are also called Tip-DCs, as they were 
shown to produce TNFα and iNOS as well as IL-10, which is in line with the data presented 
here [214].  Conversely, DCs that were differentiated with Flt3L do not secrete IL-10 or 
TNFα, but IFNγ as well as IL-12p70 [215]. Taken together, these findings assign GM-CSF 
derived DCs, like the two step DCs, to the inflammatory or Tip-DCs, rather than some kind 
of steady state DC. 
 
Regardless of the influence of TLR signalling, the cell transfer experiments in chapter 3.1.4 
demonstrated that the Flt3+ progenitor is not only a precursor for all subtypes of spleen 
DCs, but develops into all haematopoietic lineages in vivo. Although the Flt3+ progenitor 
does not contain bone marrow reconstituting potential, it does develop into both myeloid 
and lymphoid cells. Therefore the Flt3+ progenitor is not only a DC precursor, but rather a 
multipotent progenitor for all haematopoietic cell types.  
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4.2 Development of two distinct types of Langerhans cells in steady state 
and inflammation 
Mende et al. [192] showed that the Flt3+ fraction of both CMP and CLP contains LC 
precursor activity. However, these studies were done under inflammatory conditions and 
did not address the question whether skin-resident LC precursors originate from Flt3+ 
precursors under steady state conditions. Recent studies reported on a clonal Flt3+M-
CSFR+c-kit+ common DC precursor (CDP) for cDCs and pDCs in vivo [210, 211], but they did 
not address the CDP potential to differentiate into LCs.  Therefore, the Flt3+ progenitor 
used in chapter 3.1 was used for further transfer experiments in Id2-/- mice to analyse LC 
development from bone marrow progenitors. The Flt3+ progenitor is defined as 
Flt3+M-CSFR+c-kit+ CD11c-MHC-II-, but CD11b+ [160, 168] and thus is removed by the 
frequently used lineage depletion protocols, including the protocols by Onai et al. and 
Naik et al., that contain anti-CD11b antibody during stem/progenitor cell purification 
[210, 211]. The results reported here now demonstrate that the Flt3+ progenitor 
repopulates LCs without overt inflammation, indicating that under steady state conditions 
LCs can indeed develop, like other DC subtypes, from Flt3+ haematopoietic precursors. 
However, the LCs that developed after Flt3+ progenitor transfer show some differences 
compared to steady state or bone marrow derived LCs. They appear bigger in size, display 
more dendrites, and express less langerin. Thus, they resemble more the mo-LCs rather 
than classical LCs. It remains to be further analysed if this is due to the low amount of 
GM-CSF present in the amplification medium, which could direct the Flt3+ progenitor 
already to the monocyte lineage or due to preparation of the Flt3+ progenitor. 
 
A growing body of data indicates that LCs are unique in their development compared to 
other DC subtypes, but the mechanisms that regulate LC development and homeostasis 
have not been fully elucidated. Several studies demonstrate that LCs can self-renew in the 
epidermis in steady state since about 2-3% of LCs are in cell cycle [26]. A further concept 
suggests a local pool of proliferating haematopoietic precursor cells [83] that populate 
the skin during embryonic development [186, 216]. Moreover, the data presented in this 
study now ascribe Id2 a key function in LC homeostasis and development from such 
haematopoietic precursor cells as Id2-/- mice lack LCs. Additionally, this study 
demonstrates that these LC precursors are still present in bone marrow of adult Id2+/+ 
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mice and reconstitute epidermal LCs as well as langerin+ dDCs in transplantation 
experiments. This suggests that Id2-/- mice not only lack LCs and langerin+ dDCs, but also 
show a defect in their respective precursors in bone marrow. Yet, the identity of these 
bone marrow precursors and the question if they are present in Id2 deficient mice at all 
or just have impaired differentiation potential needs to be further analyzed. 
 
The absence of LCs in Id2-/- mice has allowed the comparative analysis of LC development 
from bone marrow and Gr-1hi monocytic LC precursors. It could be demonstrated that LC 
development from bone marrow cells in steady state requires Id2, while their 
development from Gr-1hi monocytes is independent of Id2, but requires an inflammatory 
stimulus, such as UV irradiation. This suggests two independent pathways for LC 
development under steady state and inflammatory conditions, respectively (Figure 4-1).  
 
Figure 4-1: Model for LC development in steady state and under inflammatory conditions. 
In steady state LCs develop from either HSC or a local precursor in skin strictly Id2-dependent (dashed line). 
These LCs stably populate the epidermis and self-renew throughout life. During inflammation LCs can 
develop from Gr-1
hi
 monocytes and this is independent of Id2 (solid line).  However, Gr-1
hi
 monocytes give 
rise to only transient LCs. HSC, haematopoietic stem cell; MPP, multi-potent progenitor. 
 
Furthermore, these results are in agreement with previous studies on a Gr-1hi monocytic 
LC precursor that repopulates LCs in the epidermis under inflammatory condition [63]. 
This Gr-1hi monocytic LC precursor is present in Id2-/- mice, yet does not repopulate 
classical LCs under steady state conditions. Importantly, this study demonstrates that  
Id2-/- Gr-1hi monocytic precursors are recruited into epidermis and develop into mo-LCs 
following UV irradiation, indicating a strict requirement of inflammatory stimuli for this LC 
precursor. However, mo-LCs appear to be different from classical LCs observed under 
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steady state conditions. They exhibit more dendrites in epidermal sheets and lower 
langerin expression than classical LCs. Moreover, mo-LCs are not capable of longterm 
repopulation of the epidermis. All this might refer to a remnant of their monocytic origin.  
 
What would be the advantage of having two separate LC differentiation pathways? One 
advantage would clearly be to allow increased numbers of LCs to be deployed quickly to 
communicate potential dangers and to initiate an immune response during inflammation.  
Another one would guarantee a quick replacement for activated and emigrated LCs to 
reduce further vulnerability during an infection. This is supported by the fact that DCs can 
be generated from monocytes in vitro in the presence of GM-CSF, which establish the 
concept that DC homeostasis is critically dependent on conditions of quiescence or 
inflammation [53]. The factors that govern this difference are largely unknown. However, 
results from this study have established that LCs can indeed develop by different 
pathways and that Id2 is one of the major factors for classical LC development, but not 
mo-LC development.   
 
Recent studies found langerin expression also in a subset of dermal DCs, showing that 
langerin is not exclusively confined to epidermal LCs [189-191]. Remarkably, as 
demonstrated here, Id2-/- mice also lack these langerin+CD11c+ dDCs and upon UV-
induced inflammation Gr-1hi monocytes failed to compensate for this deficiency. Thus, 
the question arises whether langerin+ dDCs and LCs are developmentally interrelated and 
whether or not they share a common precursor in steady state or inflammation. It could 
be demonstrated that Gr-1hi monocytes do not develop into langerin+ dDCs after UV 
irradiation in Id2-/- mice, but give rise exclusively to LCs. This argues against a common 
precursor for LCs and langerin+ dDCs at least under inflammatory conditions. 
Furthermore, the data presented here demonstrate that the Flt3+ progenitor does 
repopulate LCs, but not langerin+ dDCs in transplantation experiments, also arguing 
against a common precursor in steady state. The experiments of Nagao et al. further 
support this conclusion showing that LCs and langerin+ dDCs develop from different 
precursors by using langerin-Diphtheria toxin receptor bone marrow chimeras [217]. 
After the selective ablation of both LCs and langerin+ dDCs by Diphtheria toxin the 
repopulated LCs remained of host origin, whereas langerin+ dDCs developed from donor 
bone marrow cells.  
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Langerin+ dDCs and LCs also differ in cell surface marker expression: (i) langerin+ dDCs, but 
not LCs express CD103, and (ii) LCs express high levels of CD11b and are positive for 
EpCAM and F4/80, while langerin+ dDCs are low or negative for these markers [26]. The 
langerin+ DCs in this study obtained from bone marrow cultures with GM-CSF are CD103- 
and express E-cadherin, Gr-1, F4/80 and CD11b (Figure 3-21), and thus strikingly resemble 
LCs rather than langerin+ dDCs. Intriguingly, development of langerin+ DCs in vitro does 
not require Id2 and thus appears to follow a pathway similar to in vivo mo-LC 
differentiation from Gr-1hi monocytes under inflammatory conditions (Figure 4-1). 
 
Id2 is a member of the Id family of HLH transcription regulators that contain the highly 
conserved HLH domain but lack the basic domain required for DNA binding. The four Id 
proteins (Id1-Id4) can form heterodimers with activating bHLH transcription factors, such 
as E2A, and thus act as negative regulators of transcription [201, 202]. Several lines of 
evidence suggest that Id2 and Id3 have both distinct as well as overlapping activities in 
lymphocyte development [157, 218]. This includes DC differentiation, especially as both 
Id2 and Id3 are direct target genes of TGFβ1/SMAD-signalling [156, 219, 220]. Therefore, 
Id2 and Id3 might function in a cooperative manner in DC differentiation with both 
distinct and common target genes downstream of the TGFβ1 signalling pathway.  
Id3 was expressed in DCs from Id2-/- bone marrow cultures containing GM-CSF, but much 
lower in GM-CSF cultures from Id2+/+ mice. Thus, Id3 might substitute for Id2 under 
inflammatory conditions. This might account for the observed Id2-independent 
differentiation of Gr-1hi monocytes into langerin+ mo-LCs in vivo and the formation of 
langerin+ and Birbeck granule+ DCs in vitro.  
 
Taken together, these data emphasize the high degree of plasticity observed in DC 
development and reveal distinct mechanisms for LC development under steady state and 
inflammatory conditions.  
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4.3 The influence of Id2 in lymphoid organ DC development 
So far it was shown that Id2-/- mice have reduced numbers of DCs in spleen, and that the 
splenic CD8α+ cDCs were markedly reduced. Interestingly, thymic CD8α+ cDC 
development is not perturbed in Id2-/- mice, indicating a different and Id2-independent 
origin of these cells. Careful studies on thymic cDC development by parabiotic mice 
revealed two patterns of thymic cDC development. One is simultaneously to the cyclical 
entry of T-cell precursors into the thymus, and these precursors were found to have the 
potential to develop into CD8α+ cDCs if transferred into the thymus of irradiated 
recipients. The other is unrelated to T-cell developmental kinetics and indicates a more 
continuous input from the bloodstream [197]. Therefore, the data presented here 
suggest that splenic CD8α+ cDCs originate from bone marrow in an Id2-dependent 
mechanism, while thymic CD8α+ cDCs develop locally in thymus from an early T cell/ DC 
precursor, independent of Id2. 
 
Furthermore, this study demonstrates that also CD8α+langerin+ cDCs are absent in spleen 
as well as in thymus of Id2 deficient mice, whereas CD8α- cDCs were apparently not 
affected. Hence, the common absence of CD8α+langerin+ DCs in spleen and thymus points 
to a precursor for these cells that originates from bone marrow, and requires Id2 for 
either its development or its migration from bone marrow into lymphoid organs. 
However, it cannot be ruled out that also thymic T cell/DC precursor could give rise to 
CD8α+langerin+ cDCs, and that this differentiation remains Id2-dependent. 
In addition, this chapter shows that Id2 deficiency leads to an increase in splenic pDCs, 
whereas the B cell compartment remained unchanged, although it is assumed that these 
cell types share early events in their development [81]. Thus, Id2 has a selective impact 
on the development of distinct DC subsets rather than on the entire DC development. 
 
The absence of Id2 also influences other lymphoid cell lineages, such as T cells. Analysis of 
spleen and thymus revealed a striking decrease in CD8+ T cells and a subsequent higher 
proportion of CD4+ T cells in Id2-/- mice. 
An increase in the relative percentage of mature single positive thymocytes, such as the 
CD4+ population described here, can arise through several mechanisms. For example, 
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either aberrant proliferation of the CD4+ populations, increased frequency of apoptosis 
within the CD8+ population, or increased maturation of the double positive cells towards 
the CD4+ population could explain the phenotypical changes observed in the Id2 deficient 
mice. 
Previous studies have led to the hypothesis that Id proteins function in lineage decision 
by inhibiting E protein activity and preventing T lymphopoiesis [205].  
Furthermore, a recent study showed that Id2 is essential in regulating the survival of 
effector CD8+ T cells and influences their differentiation to memory cells [221]. Cannarile 
and colleagues found that  Id2  was  upregulated  in  CD8+  T  cells  and  remained high in 
memory  cells.  CD8+ T cells from Id2-/- mice could be activated normally by antigen, 
proliferated and differentiated to effector cells, but ultimately failed to accumulate in 
numbers and the decreased frequency of antigen-specific CD8+ T cells from Id2-/- mice 
was maintained during the transition to the memory population.  Although Id2 deficient 
CD8+ T cells showed no defect in proliferation, they were much more susceptible to 
apoptosis, correlating with the loss of cell numbers. Thus, the CD8+ T cell population of 
Id2-/- mice undergoes “premature” contraction due to increased cell death while 
proliferating normally, demonstrating that inhibition of E proteins by Id2 is important for 
sustained survival [221]. 
  
 
4.4 Id2 antagonizes the function of activating bHLH proteins 
So far, it could be shown that Id2 is required for the development of several DC subtypes. 
Id2 is known to function by repressing E protein activity. Hence, the impact of the 
simultaneous deletion of Id2 and E47 was investigated. Loss of E47 reduced total E 
protein activity sufficiently to allow DC development in the absence of Id2, indicating that 
Id2 is the major antagonist of E proteins in these cells. Moreover, the data presented here 
provide genetic evidence that the interaction between an E and Id proteins in vivo is 
necessary for DC development. However, the role of Id proteins in supporting DC lineage 
specification requires further investigation. 
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In the absence of Id2, essentially no langerin+ DCs are found in skin. Importantly, section 
3.4 shows that lowering E protein activity in Id2-/- mice by deletion of E47 results in the 
restoration of langerin+ DCs in epidermis and dermis.  
CD45+ cells, which are highly decreased in skin of Id2-/- mice are also present in epidermis 
and dermis of dko mice, although at reduced levels, leading to the suggestion that they 
may fail to emigrate from the periphery. Therefore, appropriate regulation of E protein 
activity may be critical for CD45+ cells to exit the bone marrow and accumulate in 
peripheral tissues, such as the skin.  
CD8α+ cDCs in spleen as well as CD8α+langerin+ cDCs are also absent in Id2-/- mice. 
However, deletion of E47 in Id2-/- mice fails to restore CD8α+ cDCs in spleen and 
CD8α+langerin+ cDCs in spleen or thymus, suggesting that suppression of alternative E 
proteins by Id2 is required for their development. 
 
The increase in pDCs observed in Id2-/- mice in Figure 3-28 was not seen in Id2ko mice, but 
in dko mice. The pDC increase in the latter is most probably not representing the in vivo 
state, but an accidental outlier, as recent studies showed that E2-2, but not E2A is 
important for pDC development [222].  
Nevertheless, the normal frequency of pDCs in Id2ko mice could indicate that the role of 
Id2 in pDC development may be strain dependent. Id2-/- mice used in section 3.3 are on 
the 129/SvJ background, whereas dko mice used in chapter 3.4 are on a mixed 129/SvJ 
FVB/NJ background. The interesting possibility that strain differences exist requires 
further investigation and may indicate differential regulation of Id or E proteins in 
different strains of mice, which has not yet been reported. 
 
The shift of splenic and thymic T cells towards the CD4+ population seen in section 3.3 
was retained in dko mice, although the CD8+ T cells were partially restored; at least in 
spleen. This is consistent with other studies showing that thymocyte development is not 
influenced by E2A alone, but in concert with HEB, another member of the bHLH family 
[201]. Collectively, these observations raise the possibility that both E and Id proteins play 
a role in controlling the effector functions of CD8 T cells. Additional studies will be 
required to determine the role of these proteins in CD8 T cells and how their expression is 
regulated. 
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In summary, these data indicate that the major function of Id2 in lymphoid differentiation 
is to control E protein activity and that the excess in E protein activity is the major cause 
of the lymphoid phenotypes in Id2-/- mice. These findings redefine the essential functions 
of Id2 in DC development and provide insight into the dynamic regulation of E and Id 
proteins during this process. However, future studies are necessary to address the 
requirement for modulation of E protein activity in DCs and whether E proteins play a 
positive role in any aspect of DC development or function. 
 
Last but not least the important question remains whether langerin expression is Id2 
dependent and which role do E proteins play in its regulation? So far, langerin expression 
is only described for DCs and this study demonstrates that Id2-/- mice lack exclusively the 
langerin+ fraction of DCs in different tissues; except for the splenic CD8α+ cDCs where the 
defect is more comprehensive. The hypothesis that all these different langerin+ DC types 
develop from a common precursor is quite unlikely, as several precursors have already 
been identified for the different DC subtypes. Nevertheless, it is supposable that these DC 
subtypes undergo certain steps during their development, where Id2 is essential to 
proceed in differentiation. The expression of langerin might be a good example for such a 
requirement. How Id2 exactly regulates langerin expression and whether E proteins have 
an important part in it, remains to be investigated. The data in this study suggest that Id2 
acts indeed through E47 to induce langerin expression, at least in skin DCs. The absence 
of langerin+ cDCs in dko mice also indicates that E47 might not be the only E protein that 
interacts with Id2 to regulate langerin expression. This is actually quite likely, as Id2 is 
reported to interact efficiently with all E proteins in vitro [208]. 
Two possible models could explain how the interaction of Id2 and E proteins controls 
langerin expression. The first one is based on the fact that E proteins belong to a group of 
activating HLH proteins, which are negatively regulated by Id2. In this case, an E protein, 
such as E47, would activate the expression of a langerin inhibitor and this activation 
would be prevented when Id2 is present. The second possibility assumes that E proteins 
can not only activate transcription, but also block it. This is a rather unusual situation, 
although there is evidence that exactly this happens during thymocyte development 
[223]. Yang et al. propose that E47 negatively regulates CD5 expression by interacting 
with the κE2 site in the CD5 regulatory promoter and that decreases in E47 in response to 
developmental signals are critical to the progressive increase in CD5 expression as 
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thymocytes mature [223]. Something similar could be true for the langerin promoter. In 
addition, this latter hypothesis would explain why langerin expression can occur in Id2-/- 
mice during inflammation when Id3 is substituting for Id2. 
Taken together these data suggest an essential role of HLH proteins in the regulation of 
langerin expression. It would be exciting to understand the molecular regulation of 
langerin and would also provide enormous help in addressing its functional properties, 
which are still controversial. 
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Genotyping of Id2 SV129 Mice 
DNA was isolated from tailcuts by the use of the NucleoSpin Tissue kit (Macherey & 
Nagel) according to manufacturers’ instruction. 
 
Primer Mix B 
Id2-2 for GCA TCC CCC AGA ACA AGA AG 
Id2-2 rev GTA GCC CCC CTC CTC CTT TC 
(at a ratio of 1:1) 
 
PCR reaction      PCR parameter 
 
 
 
 
 
 
 
 
Product  
WT Band: ~500bp   
 
 
Primer Mix C   
Id2S:  TCT GAG CTT ATG TCG AAT GAT AGC  
Id2AS:  CGT GTT CTC CTG GTG AAA TGG CTG  
Id2Neo: TCG TGC TTT ACG GTA TCG CCG CTC  
(at a ratio of 4:2:1) 
  
PCR reaction      PCR parameter 
 
 
 
 
 
 
 
 
 
 
Product  
WT Band: ~900bp   
KO Band: ~400bp 
 
Reagent Volume 
10x PCR Puffer + (NH4)2SO4 5µl 
MgCl2
 
(25mM)
  3µl 
dNTPs (10mM) 1µl 
Primer Mix A 2µl 
DMSO 2µl 
DNA 3µl 
Taq Polymerase (homemade) 1µl 
MilliQ 33µl 
 total 50µl 
Step Temperature Cycles 
Initial activation 5min at 95°C 1 
Denaturation 45sec at 95°C 
40 Annealing 30sec at 60°C 
Extension 1min at 72°C 
Final extension 5min at 72°C 1 
Reagent Volume 
10x PCR Puffer + (NH4)2SO4 5µl 
MgCl2
 
(25mM)
  3µl 
dNTPs (10mM) 1µl 
Primer Mix C 3µl 
DMSO 2µl 
DNA 5µl 
Taq Polymerase (homemade) 1µl 
MilliQ 30µl 
 total 50µl 
Step Temperature Cycles 
Initial activation 5min at 95°C 1 
Denaturation 45sec at 95°C 
40 Annealing 30sec at 60°C 
Extension 1min at 72°C 
Final extension 5min at 72°C 1 
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Genotyping of E47-Id2 Mice  
DNA was isolated from tailcuts by the use of the NucleoSpin Tissue kit (Macherey & 
Nagel) according to manufacturers’ instruction. 
 
Genotyping for Id2 was similar as for Id2 SV129 mice.  
 
Primer Mix E47 
E47 bas for: CAG ATG AGG TGC TGT CCC  
E47 bas rev: CAG GAT CAC CTG CAC CGC  
(at a ratio of 1:1) 
 
PCR reaction      PCR parameter 
 
 
 
 
 
 
 
 
Product  
WT Band: ~200bp   
KO Band: ~1500bp 
 
Reagent Volume 
10x PCR Puffer + (NH4)2SO4 5µl 
MgCl2
 
(25mM)
  3µl 
dNTPs (10mM) 1µl 
Primer Mix E 2µl 
DMSO 2µl 
DNA 3µl 
Taq Polymerase (homemade) 1µl 
MilliQ 33µl 
 total 50µl 
Step Temperature Cycles 
Initial activation 5min at 95°C 1 
Denaturation 1min at 95°C 
38 Annealing 30sec at 61°C 
Extension 2min at 72°C 
Final extension 5min at 72°C 1 
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